###begin article-title 0
###xml 82 85 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 109 114 <span type="species:ncbi:10090">Mouse</span>
Relief of Preintegration Inhibition and Characterization of Additional Blocks for HIV Replication in Primary Mouse T Cells
###end article-title 0
###begin p 1
Conceived and designed the experiments: DL JZ. Performed the experiments: JZ. Analyzed the data: DL JZ GD. Wrote the paper: DL JZ GD. Other: Performed DNA extraction: GD.
###end p 1
###begin p 2
###xml 407 408 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 506 507 506 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1224 1225 1220 1221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 45 48 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 206 212 <span type="species:ncbi:10090">murine</span>
###xml 383 388 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 422 427 <span type="species:ncbi:9606">human</span>
###xml 448 463 <span type="species:ncbi:10090">transgenic mice</span>
###xml 497 502 <span type="species:ncbi:10090">mouse</span>
###xml 553 558 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 563 568 <span type="species:ncbi:10090">mouse</span>
###xml 578 583 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 656 661 <span type="species:ncbi:9606">human</span>
###xml 711 716 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 759 764 <span type="species:ncbi:10090">mouse</span>
###xml 868 873 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 968 973 <span type="species:ncbi:10090">mouse</span>
###xml 1008 1011 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1184 1189 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1215 1220 <span type="species:ncbi:10090">mouse</span>
###xml 1561 1566 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1693 1698 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1714 1719 <span type="species:ncbi:10090">mouse</span>
###xml 1848 1853 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Development of a small animal model to study HIV replication and pathogenesis has been hampered by the failure of the virus to replicate in non-primate cells. Most studies aimed at achieving replication in murine cells have been limited to fibroblast cell lines, but generating an appropriate model requires overcoming blocks to viral replication in primary T cells. We have studied HIV-1 replication in CD4+ T cells from human CD4/ CCR5/Cyclin T1 transgenic mice. Expression of hCD4 and hCCR5 in mouse CD4+ T cells enabled efficient entry of R5 strain HIV-1. In mouse T cells, HIV-1 underwent reverse transcription and nuclear import as efficiently as in human T cells. In contrast, chromosomal integration of HIV-1 proviral DNA was inefficient in activated mouse T cells. This process was greatly enhanced by providing a secondary T cell receptor (TCR) signal after HIV-1 infection, especially between 12 to 24 h post infection. This effect was specific for primary mouse T cells. The pathways involved in HIV replication appear to be PKCtheta-, CARMA1-, and WASp-independent. Treatment with Cyclosporin A (CsA) further relieved the pre-integration block. However, transcription of HIV-1 RNA was still reduced in mouse CD4+ T cells despite expression of the hCyclin T1 transgene. Additional post-transcriptional defects were observed at the levels of Gag expression, Gag processing, Gag release and virus infectivity. Together, these post-integration defects resulted in a dramatically reduced yield of infectious virus (300-500 fold) after a single cycle of HIV-1 replication. This study implies the existence of host factors, in addition to those already identified, that are critical for HIV-1 replication in mouse cells. This study also highlights the differences between primary T cells and cell lines regarding pre-integration steps in the HIV-1 replication cycle.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 412 415 412 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 420 421 416 417 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 421 423 417 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/</sup>
###xml 409 423 409 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rag<sup>&#8722;/&#8722;</sup>&#947;<sub>c</sub><sup>&#8722;/</sup></italic>
###xml 423 424 419 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 459 460 455 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 472 475 468 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Baenziger1">[1]</xref>
###xml 477 480 473 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-McCune1">[2]</xref>
###xml 523 530 519 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 702 703 698 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 826 829 822 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Baenziger1">[1]</xref>
###xml 25 28 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 273 278 <span type="species:ncbi:9606">human</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 356 361 <span type="species:ncbi:9606">human</span>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
###xml 449 454 <span type="species:ncbi:9606">human</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
###xml 531 536 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 587 592 <span type="species:ncbi:9606">human</span>
###xml 685 689 <span type="species:ncbi:10090">mice</span>
###xml 728 732 <span type="species:ncbi:10090">mice</span>
###xml 764 769 <span type="species:ncbi:9606">human</span>
###xml 778 783 <span type="species:ncbi:10090">mouse</span>
A small animal model for HIV infection and pathogenesis would be invaluable for basic research as well as for vaccine development. Humanized mice can be used for this purpose. The xenotransplant models include severe combined immunodeficiency (SCID) mice transplanted with human fetal thymus or liver cells (SCID-Hu (Thy/Liv)), SCID mice transplanted with human peripheral blood lymphocytes (Hu-PBL-SCID) and Rag-/-gammac-/- mice reconstituted with human CD34+ stem cells [1], [2]. Although these mice have been useful for in vivo HIV-1 pathogenesis studies, as they have aspects of the human immune system, each model has its limitations. B cells fail to develop in SCID-Hu (Thy/Liv) mice, and in CD34+ stem cell reconstituted mice, abnormal interactions between human TCR and mouse MHC lead to defects in T cell development [1], which represents a serious problem for most of the xenotransplant models.
###end p 4
###begin p 5
###xml 319 322 319 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Cameron1">[3]</xref>
###xml 324 327 324 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Wu1">[4]</xref>
###xml 657 660 657 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Keppler1">[5]</xref>
###xml 662 665 662 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Goffinet1">[6]</xref>
###xml 869 872 869 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Keppler1">[5]</xref>
###xml 100 105 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 313 318 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 376 379 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 480 485 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 490 496 <span type="species:ncbi:9606">humans</span>
###xml 562 567 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 580 584 <span type="species:ncbi:10116">rats</span>
###xml 600 605 <span type="species:ncbi:9606">human</span>
###xml 614 619 <span type="species:ncbi:9606">human</span>
###xml 645 650 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 675 678 <span type="species:ncbi:10116">rat</span>
###xml 746 751 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 774 777 <span type="species:ncbi:10116">rat</span>
Various cell types in the immune system contribute to the initiation, progression and prevention of HIV-1 induced disease. Dendritic cells (DCs) and macrophages, for example, are required for the initiation of adaptive immunity, but potentially also harbor viruses and thus contribute to enhancing infection with HIV-1 [3], [4]. To understand the role of the immune system in HIV pathogenesis, it is necessary to have an intact host immune system in small animals infectable with HIV-1. In humans, combinations of CD4 and CXCR4 or CCR5 can mediate cell entry of HIV-1. Cells from rats transgenic for human CD4 and human CCR5 were susceptible to HIV-1 entry [5], [6]. In this rat model, primary macrophages and microglia supported some productive HIV-1 replication. However, rat T cells were unable to support virus spreading due to putative post-transcriptional blocks [5].
###end p 5
###begin p 6
###xml 233 236 233 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-De1">[7]</xref>
###xml 238 241 238 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Toggas1">[8]</xref>
###xml 243 246 243 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Corboy1">[9]</xref>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Garza1">[10]</xref>
###xml 354 355 354 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 569 573 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Wei1">[11]</xref>
###xml 687 688 687 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 706 710 706 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Sun1">[12]</xref>
###xml 894 898 894 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Browning1">[13]</xref>
###xml 900 904 900 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Sawada1">[14]</xref>
###xml 1019 1026 1019 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1078 1082 1078 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Browning1">[13]</xref>
###xml 1084 1088 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Sawada1">[14]</xref>
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 66 70 <span type="species:ncbi:10090">Mice</span>
###xml 84 87 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 188 193 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 259 264 <span type="species:ncbi:10090">mouse</span>
###xml 291 294 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 395 400 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 439 444 <span type="species:ncbi:10090">mouse</span>
###xml 478 481 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 595 600 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 624 639 <span type="species:ncbi:10090">transgenic mice</span>
###xml 651 656 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 782 787 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 801 806 <span type="species:ncbi:10090">mouse</span>
###xml 814 829 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 849 854 <span type="species:ncbi:9606">human</span>
###xml 960 964 <span type="species:ncbi:10090">mice</span>
###xml 980 985 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1062 1077 <span type="species:ncbi:10090">transgenic mice</span>
Some progress has been made in developing mouse models for HIV-1. Mice that express HIV transgenes have been generated using both the full length provirus and individual components of the HIV-1 genome including Nef, Tat, LTR and Env [7], [8], [9], [10]. Some mouse strains expressing single HIV proteins developed symptoms of AIDS such as wasting and CD4+ T cell depletion. However, full length HIV-1 RNAs are transcribed inefficiently in mouse cells. hCyclin T1 interacts with HIV Tat protein in a species-restricted manner to enhance RNA transcription and processing [11]. In JRCSF (R5 tropic HIV-1) and hCyclin T1 double transgenic mice, increased HIV-1 expression correlated with CD4+ T cell depletion [12]. In addition to hCyclin T1, hCD4 and hCCR5 or hCXCR4 are necessary for HIV-1 infection of mouse cells. Transgenic mice that express these human genes have been generated and reported [13], [14]. However, these genes alone are not sufficient to make mice susceptible to HIV-1. No virus spreading was observed in vivo for either hCD4/CCR5 or hCD4/CXCR4 transgenic mice [13], [14].
###end p 6
###begin p 7
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Bieniasz1">[15]</xref>
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Mariani1">[16]</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Coskun1">[17]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Mariani2">[18]</xref>
###xml 497 501 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Coskun1">[17]</xref>
###xml 961 965 961 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Hubner1">[19]</xref>
###xml 967 971 967 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Zheng1">[20]</xref>
###xml 973 977 973 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Swanson1">[21]</xref>
###xml 979 983 979 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Hatziioannou1">[22]</xref>
###xml 985 989 985 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Reed1">[23]</xref>
###xml 991 995 991 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Chen1">[24]</xref>
###xml 85 88 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 237 242 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 359 364 <span type="species:ncbi:10090">mouse</span>
###xml 365 370 <span type="species:ncbi:9606">human</span>
###xml 437 442 <span type="species:ncbi:9606">human</span>
###xml 821 826 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 840 846 <span type="species:ncbi:10090">Murine</span>
###xml 883 888 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1249 1254 <span type="species:ncbi:10090">mouse</span>
###xml 1274 1279 <span type="species:ncbi:10090">mouse</span>
###xml 1290 1293 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1454 1457 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1493 1498 <span type="species:ncbi:10090">mouse</span>
Studies searching for additional factors involved in species-specific restriction of HIV replication have mainly focused on cell lines such as NIH 3T3 and A9 cells [15], [16], [17]. NIH 3T3 cells expressing hCD4/CCR5/Cyclin T1 supported HIV-1 entry and integration. Virus assembly was reported to be a major post-integration block, which could be relieved in mouse-human heterokaryons [18]. A9-based somatic cell hybrid lines containing human chromosome 2 can efficiently release infectious virus [17]. The host factors required for viral release in these systems have not yet been identified. Several groups have tried to overcome the assembly/release block by altering the virus, e.g. mutation of matrix protein to enhance membrane targeting, over-expression of Gag to increase intracellular p24 level, replacing MA of HIV-1 with that of Murine Leukemia Virus (MLV), inhibition of HIV-1 RNA over-splicing, and use of the alternative RNA transport element CTE [19], [20], [21], [22], [23], [24]. We found that some lines of 3T3 cells could support efficient Gag processing and virus release, while other lines could not. Because of these discrepancies, we were concerned that 3T3 cells may not be an appropriate model for studying virus release in mouse cells. Moreover, a mouse model for HIV replication and pathogenesis will require that T lymphocytes can be infected with the virus. It is therefore critical that we have a clear understanding of how HIV replication is affected in primary mouse T cells.
###end p 7
###begin p 8
###xml 72 76 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Baumann1">[25]</xref>
###xml 984 988 980 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Berthoux1">[26]</xref>
###xml 990 994 986 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Sokolskaja1">[27]</xref>
###xml 996 1000 992 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Towers1">[28]</xref>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
###xml 184 189 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 365 370 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 382 387 <span type="species:ncbi:9606">human</span>
###xml 392 397 <span type="species:ncbi:10090">mouse</span>
###xml 479 484 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 513 518 <span type="species:ncbi:10090">mouse</span>
###xml 533 538 <span type="species:ncbi:9606">human</span>
###xml 584 589 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 622 627 <span type="species:ncbi:10090">mouse</span>
###xml 759 764 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
###xml 948 953 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 967 977 <span type="species:ncbi:9505">owl monkey</span>
###xml 1053 1058 <span type="species:ncbi:10090">mouse</span>
HIV-1 infection in transformed mouse T cell lines was reported recently [25]. In that study, immortalized mouse T cell lines that expressed hCD4 and hCCR5 were found to support normal HIV-1 entry, but reverse transcription and nuclear import were reduced as compared to NIH 3T3 cells or human T cell lines. In the current study, we have compared the replication of HIV-1 in primary human and mouse T cells. We found that viral entry, reverse transcription, and nuclear import of HIV-1 are as efficient in primary mouse T cells as in human T cells. Although chromosomal integration of HIV-1 proviral DNA was inefficient in mouse T cells pre-activated with anti-CD3 and anti-CD28, this block was substantially relieved by providing a secondary TCR signal after HIV-1 infection. Using mutant mice, we found that this signal is independent of the pathways involving PKCtheta, CARMA1 (CARD 11) and WASp. Treatment with CsA, which significantly enhances HIV-1 infection in owl monkey cells [26], [27], [28], additionally relieved the pre-integration block in mouse T cells.
###end p 8
###begin p 9
###xml 48 51 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 73 79 <span type="species:ncbi:10090">murine</span>
###xml 337 342 <span type="species:ncbi:10090">mouse</span>
###xml 394 399 <span type="species:ncbi:9606">human</span>
###xml 437 440 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 542 547 <span type="species:ncbi:10090">mouse</span>
###xml 571 576 <span type="species:ncbi:9606">human</span>
Although we were able to overcome blocks in the HIV replication cycle in murine cells up to proviral integration, we observed defects in transcription, despite expression of the hCyclin T1 transgene, and after transcription at the levels of Gag expression, Gag processing and Gag release. Furthermore, infectivity of virus released from mouse T cells was lower than that of virus released from human T cells. These defects subsequent to HIV integration contributed in aggregate to a 300-500-fold reduction in the titer of virus released from mouse T cells as compared to human T cells.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 31 46 <span type="species:ncbi:10090">transgenic mice</span>
Primary T cells from hCD4/CCR5 transgenic mice support efficient virus entry
###end title 11
###begin p 12
###xml 92 95 92 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD4</italic>
###xml 122 143 122 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 143 146 143 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Keppler1">[5]</xref>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Sun1">[12]</xref>
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Browning1">[13]</xref>
###xml 514 515 514 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 609 618 609 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g001">Figure 1A</xref>
###xml 932 941 932 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g001">Figure 1A</xref>
###xml 8 23 <span type="species:ncbi:10090">transgenic mice</span>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 215 230 <span type="species:ncbi:10090">transgenic mice</span>
###xml 240 246 <span type="species:ncbi:9606">humans</span>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
###xml 436 441 <span type="species:ncbi:10090">mouse</span>
###xml 505 510 <span type="species:ncbi:10090">mouse</span>
###xml 621 626 <span type="species:ncbi:10090">Mouse</span>
###xml 753 768 <span type="species:ncbi:10090">transgenic mice</span>
###xml 777 782 <span type="species:ncbi:9606">human</span>
###xml 806 811 <span type="species:ncbi:10090">mouse</span>
We used transgenic mice in which expression of human CD4 and CCR5 was directed by the human CD4 regulatory sequences (see Materials and Methods[5], [12]), in contrast to the Lck promoter used in published hCD4/CCR5 transgenic mice [13]. In humans, CD4 is expressed in T cells, macrophages and DCs. To characterize the cellular expression profiles of hCD4 and hCCR5 in these mice, we performed flow cytometry analysis by co-staining for mouse CD4, hCD4, and hCCR5. Both transgenes were highly expressed on mouse CD4+ T cells in all organs examined, including blood, mesenteric lymph nodes, spleen, and thymus (Figure 1A). Mouse bone marrow derived DCs also expressed hCD4/CCR5 (data not shown). hCCR5 was expressed at a much higher level on T cells from transgenic mice than on human T cells. Activation of mouse T cells using plate-coated anti-CD3 and -CD28 antibodies induced marked down-regulation of hCCR5 from the cell surface (Figure 1A and Discussion).
###end p 12
###begin title 13
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 37 52 <span type="species:ncbi:10090">transgenic mice</span>
###xml 64 69 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Primary CD4+ T cells from hCD4/hCCR5 transgenic mice support R5 HIV-1 entry.
###end title 13
###begin p 14
###xml 211 212 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 231 232 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 381 382 381 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 474 475 474 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 922 923 909 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
###xml 150 155 <span type="species:ncbi:9606">human</span>
###xml 164 169 <span type="species:ncbi:9606">human</span>
###xml 202 207 <span type="species:ncbi:10090">mouse</span>
###xml 222 227 <span type="species:ncbi:10090">Mouse</span>
###xml 333 348 <span type="species:ncbi:10090">transgenic mice</span>
###xml 396 401 <span type="species:ncbi:9606">human</span>
###xml 455 460 <span type="species:ncbi:9606">human</span>
###xml 465 470 <span type="species:ncbi:10090">mouse</span>
###xml 636 641 <span type="species:ncbi:10090">mouse</span>
###xml 657 662 <span type="species:ncbi:9606">human</span>
###xml 868 883 <span type="species:ncbi:10090">transgenic mice</span>
###xml 947 951 <span type="species:ncbi:10090">mice</span>
(A) Single cell suspensions prepared from mouse blood, mesenteric lymph node, spleen and thymus were analyzed by flow cytometry for the expression of human CD4 and human CCR5. Plots shown were gated on mouse CD4+ T cells. Mouse CD4+ T cells activated by plate-bound anti-CD3/28 were also stained for hCD4/hCCR5expression. hCyclin T1 transgenic mice served as negative controls. CD4+ T cells from human PBMCs were also analyzed for comparison. (B) Resting human and mouse CD4+ T cells were infected with JRCSF viruses containing Vpr-beta-lactamase at MOI of 1. Cells were then loaded with CCF2-AM and incubated at 18-20degreesC for 2 h (mouse) or overnight (human) before fixation and flow cytometry analysis. FITC channel was used to detect the substrate and DAPI channel for cleaved product. TAK-779 (1 microM) was used to inhibit CCR5 mediated entry. Cells from non-transgenic mice were used as negative control. (C) CD4+ T cells from hCD4/CCR5 mice were activated with plate-bound anti-CD3/28 and analyzed as in panel B. All data represented three independent experiments.
###end p 14
###begin p 15
###xml 65 69 62 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Cavrois1">[29]</xref>
###xml 107 108 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 585 586 576 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 670 679 661 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g001">Figure 1B</xref>
###xml 974 975 965 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1080 1089 1071 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g001">Figure 1C</xref>
###xml 1526 1527 1517 1518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1548 1557 1539 1548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002035.s001">Figure S1</xref>
###xml 1582 1586 1573 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Baumann1">[25]</xref>
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 194 199 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 467 472 <span type="species:ncbi:9606">human</span>
###xml 576 581 <span type="species:ncbi:10090">mouse</span>
###xml 640 645 <span type="species:ncbi:10090">mouse</span>
###xml 827 842 <span type="species:ncbi:10090">transgenic mice</span>
###xml 938 943 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 965 970 <span type="species:ncbi:10090">mouse</span>
###xml 1176 1180 <span type="species:ncbi:10090">mice</span>
###xml 1219 1224 <span type="species:ncbi:10090">mouse</span>
###xml 1244 1249 <span type="species:ncbi:9606">human</span>
###xml 1309 1314 <span type="species:ncbi:9606">human</span>
###xml 1330 1335 <span type="species:ncbi:10090">mouse</span>
###xml 1497 1502 <span type="species:ncbi:9606">human</span>
###xml 1507 1512 <span type="species:ncbi:10090">mouse</span>
To measure virus entry, we utilized the Vpr-beta-lactamase assay [29]. Purified mouse and human resting CD4+ T cells were infected at different multiplicities of infection (MOIs) with JRCSF (R5 HIV-1) containing Vpr-beta-lactamase. Infected cells were then loaded with CCF2-AM. The cleavage of CCF2-AM by beta-lactamase was monitored by flow cytometry using the FITC and DAPI channels, for un-cleaved substrate and cleaved products, respectively. At MOI of 1, 30% of human T cells supported virus entry, which was completely blocked by the CCR5 inhibitor TAK-779. For resting mouse CD4+ T cells, entry was more efficient, with about 90% of mouse cells supporting entry (Figure 1B). Treatment with TAK-779 had only a modest effect, most likely due to the extremely high level of CCR5 expression at the surface of T cells in the transgenic mice. Since activation down-regulates hCCR5 expression, we tested the ability of TAK-779 to inhibit HIV-1 entry into activated mouse CD4+ T cells. Under these conditions, 20% of the cells were infected, and TAK-779 effectively blocked entry (Figure 1C). There was no virus entry in control experiments with cells from hCD4/hCCR5-negative mice. Thus, R5 virus can efficiently enter mouse T cells expressing human CD4 and CCR5. Due to the different levels of hCCR5 between human and transgenic mouse T cells, we chose to use Vesicular Stomatitis Virus G protein (VSVG)-pseudotyped virus in subsequent experiments. Entry of VSVG-pseudotyped virus was similar in human and mouse activated CD4+ T cells as shown in Figure S1 and reported previously [25].
###end p 15
###begin title 16
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
Primary mouse T cells support efficient reverse transcription
###end title 16
###begin p 17
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Sastry1">[30]</xref>
###xml 328 337 328 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002035.s002">Figure S2</xref>
###xml 77 82 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
We next evaluated the efficiency of reverse transcription following entry of HIV-1 into mouse T cells. To reduce DNA carry-over from plasmid used for transfection, virus-containing supernatants were treated with benzonase [30], which greatly decreased contamination of the viral prep with DNA, and had no effect on infectivity (Figure S2).
###end p 17
###begin p 18
###xml 99 108 99 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g002">Figure 2A</xref>
###xml 636 645 636 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g002">Figure 2A</xref>
###xml 847 856 847 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g002">Figure 2B</xref>
###xml 873 877 873 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Butler1">[31]</xref>
###xml 879 883 879 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Kim1">[32]</xref>
###xml 923 939 923 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g002">Figure 2C and 2D</xref>
###xml 1187 1208 1187 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 1390 1407 1390 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g002">Figures 2C and 2D</xref>
###xml 16 21 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
###xml 287 292 <span type="species:ncbi:10090">Mouse</span>
###xml 751 756 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 910 915 <span type="species:ncbi:9606">human</span>
###xml 1017 1022 <span type="species:ncbi:9606">human</span>
###xml 1027 1032 <span type="species:ncbi:10090">mouse</span>
###xml 1166 1171 <span type="species:ncbi:9606">human</span>
###xml 1176 1181 <span type="species:ncbi:10090">mouse</span>
###xml 1361 1366 <span type="species:ncbi:10090">mouse</span>
###xml 1375 1380 <span type="species:ncbi:9606">human</span>
###xml 1508 1513 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1540 1545 <span type="species:ncbi:10090">mouse</span>
###xml 1744 1749 <span type="species:ncbi:10090">mouse</span>
###xml 1764 1769 <span type="species:ncbi:9606">human</span>
The kinetics of HIV-1 reverse transcription were studied in activated mouse T cells at a MOI of 2 (Figure 2A). The results were similar at higher MOI (data not shown). Early and late reverse transcription products were monitored by real-time PCR with primers specific for U5 and U5-Gag. Mouse T cells were activated for 36 h, collected and frozen down at different time points post-infection. AZT was used in control cultures to confirm that the signal was reverse transcriptase dependent. AZT was added at different time points to inhibit reverse transcription and samples were collected starting from the next time point. As shown in Figure 2A, reverse transcription started soon after virus infection and peaked 12-15 h post-infection. After that, HIV-1 DNA began to be degraded. Late reverse transcription products followed the same kinetics (Figure 2B). We and others [31], [32] found similar kinetics in human cells (Figure 2C and 2D). We next compared the copy number of reverse transcription products between human and mouse primary T cells. Cell numbers were calculated based on real-time PCR for the gene encoding 18S rRNA, using a sequence common to both human and mouse (see Materials and Methods). The copy number was then normalized to cell number and was displayed as copy number per cell. Reverse transcription products were about 50% higher in mouse than in human T cells (Figures 2C and 2D). However, this increase was not statistically significant. At the peak of reverse transcription of HIV-1 (MOI = 2), each activated mouse T cell contained approximately 5 copies of early reverse transcription product and 3 copies of late reverse transcription product. We conclude that reverse transcription proceeded as efficiently in mouse T cells as in human T cells.
###end p 18
###begin title 19
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 85 90 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Primary CD4+ T cells from hCyclin T1 mice support efficient reverse transcription of HIV-1.
###end title 19
###begin p 20
###xml 88 89 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1140 1141 1136 1137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1332 1333 1328 1329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 246 249 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1161 1165 <span type="species:ncbi:10090">mice</span>
###xml 1318 1323 <span type="species:ncbi:9606">human</span>
###xml 1520 1525 <span type="species:ncbi:9606">human</span>
###xml 1542 1546 <span type="species:ncbi:10090">mice</span>
(A) Kinetics of early reverse transcription products in mouse T cells. MACS purified CD4+ T cells from three individual hCyclin T1 mice were activated for 36 h by anti-CD3/28. Cells were then spin infected with benzonase-treated VSVG-pseudotyped HIV-GFP (MOI = 2). 3 h post infection, cells were washed to remove virus and replated on anti-CD3/28. At different time points, cells were collected, washed and frozen down. DNA was isolated by phenol extraction and Real Time PCR analysis was preformed. To show the de novo formation of reverse transcription products, AZT (15 microM) was added at different time points and cells were collected as above starting from the next time point (Dashed lines). Real Time-PCR was performed using primers and probes specific for 18S rRNA (for cell number) and R-U5 (for early reverse transcription product). The copy number of reverse transcription product was then normalized to cell number and displayed as copy number per cell. (B) Kinetics of late reverse transcription products. Samples from panel A were subjected to Real Time-PCR using primers and probes specific for U5-Gag. (C, D) Activated CD4+ T cells from three mice were infected and analyzed for early (panel C) and late reverse transcription (panel D) products as described in panel A. For comparison, PHA activated human PBMC CD4+ T cells from three donors were infected and analyzed in parallel. All values represent the arithmetic means +/-SD. Data represent two independent experiments, each with cells from three human donors or three mice.
###end p 20
###begin title 21
###xml 32 47 <span type="species:ncbi:10090">transgenic mice</span>
Primary T cells from hCyclin T1 transgenic mice support efficient nuclear import (formation of 2-LTR circles) but have a defect in integration
###end title 21
###begin p 22
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Butler2">[33]</xref>
###xml 40 43 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 246 251 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A byproduct of the process by which the HIV pre-integration complex enters the nucleus and gives rise to an integrated provirus is the formation of 2-LTR circles. 2-LTR circles are formed inside the nucleus and have been used as an indicator for HIV-1 nuclear entry [33].
###end p 22
###begin p 23
###xml 126 135 126 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g003">Figure 3A</xref>
###xml 390 399 390 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g003">Figure 3A</xref>
###xml 550 553 550 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 577 580 577 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gfp</italic>
###xml 775 779 775 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Swanson1">[21]</xref>
###xml 888 892 888 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Bieniasz1">[15]</xref>
###xml 894 898 894 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Mariani1">[16]</xref>
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
###xml 108 113 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 498 503 <span type="species:ncbi:10090">mouse</span>
###xml 508 513 <span type="species:ncbi:9606">human</span>
###xml 527 530 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 625 628 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 812 815 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 859 864 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1224 1229 <span type="species:ncbi:10090">mouse</span>
###xml 1234 1239 <span type="species:ncbi:9606">human</span>
We found no difference in the level of 2-LTR circles formed in human and mouse T cells after infection with HIV-1 (R7/3-GFP) (Figure 3A). At MOI of 0.3, there is about 0.1-0.15 copy of 2-LTR circles in each activated cell. In further support of the detection of 2-LTR circles, the signals were increased about 8-10 fold when D116A integrase mutant virus in the same R7/3 backbone was used (Figure 3A). To study virus integration more directly, we monitored the expression of GFP after infection of mouse and human T cells with HIV-GFP, a virus whose nef gene was replaced with gfp. GFP is expressed from the multiply-spliced HIV RNA. The multiply-spliced RNAs are exported from the nucleus independently of the Rev-RRE system, which is thought to be inefficient in 3T3 cells [21]. In the presence of hCyclin T1, HIV-GFP virus has been used to study blocks to HIV-1 infection in 3T3 cells [15], [16]. Expression of GFP therefore indicates successful integration, although it can be influenced by other factors such as LTR promoter activity and mRNA stability. For this reason, we have also employed a PCR-based analysis of integrated proviruses in some experiments as described below, but this was not feasible for comparing mouse and human cells.
###end p 23
###begin title 24
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 78 83 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Primary CD4+ T cells from hCyclin T1 mice support efficient nuclear import of HIV-1 but less efficient integration.
###end title 24
###begin p 25
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 217 238 217 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 357 358 357 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 485 506 485 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 697 698 697 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 33 48 <span type="species:ncbi:10090">transgenic mice</span>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 383 398 <span type="species:ncbi:10090">transgenic mice</span>
###xml 449 452 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 688 693 <span type="species:ncbi:9606">human</span>
(A) CD4+ T cells from hCyclin T1 transgenic mice and human donors were activated and infected with VSVG-pseudotyped R7/3-GFP at MOI of 0.3 or its D116A integrase mutant virus with similar amount of RT as described in Materials and Methods. At 24 and 48 h post infection, cells were collected and subjected to real-time PCR specific for 2LTR circles. (B) CD4+ T cells from hCyclin T1 transgenic mice were activated and infected with VSVG-pseudotyped HIV-GFP at MOI of 2 as described in Materials and Methods. Cells were removed from anti-CD3/28 antibody at 3 h post infection. Infection was assessed by GFP expression using flow cytometry at 48 h post-infection. For comparison, activated human CD4+ T cells were infected and analyzed in parallel. All data represented three independent experiments.
###end p 25
###begin p 26
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 364 373 364 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g003">Figure 3B</xref>
###xml 6 9 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 121 126 <span type="species:ncbi:9606">human</span>
###xml 138 144 <span type="species:ncbi:10090">murine</span>
###xml 237 242 <span type="species:ncbi:9606">human</span>
###xml 400 405 <span type="species:ncbi:10090">mouse</span>
###xml 452 457 <span type="species:ncbi:9606">human</span>
Using HIV-GFP (VSVG) as an indicator virus, successful integration took place in 30-50% of CD4+ T cells in PHA-activated human PBMC. When murine T cells were stimulated with anti-CD3/28 and infected under conditions similar to those for human T cells, without secondary TCR signals, infection was very inefficient, with only about 1.5% of cells becoming infected (Figure 3B). Under these conditions, mouse T cells are therefore far less efficient than human T cells in supporting virus integration.
###end p 26
###begin title 27
###xml 39 44 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 66 72 <span type="species:ncbi:10090">murine</span>
Secondary TCR signals permit efficient HIV-1 infection of primary murine T cells
###end title 27
###begin p 28
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 114 119 <span type="species:ncbi:10090">mouse</span>
###xml 158 161 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 340 345 <span type="species:ncbi:10090">mouse</span>
###xml 378 381 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
While optimizing conditions for maximum HIV-1 infection of primary mouse T cells, we found that pre-activation of mouse T cells was not sufficient to support HIV replication, but when secondary TCR signals were provided, much of the pre-integration block was relieved. We sought to understand the role of T cell signaling in the ability of mouse cells to support infection with HIV.
###end p 28
###begin p 29
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 180 189 180 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Figure 4A</xref>
###xml 35 50 <span type="species:ncbi:10090">transgenic mice</span>
###xml 131 136 <span type="species:ncbi:10090">mouse</span>
###xml 150 153 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Primary CD4+ cells from hCyclin T1 transgenic mice were purified and stimulated as described above. We then infected the activated mouse T cells with HIV-GFP (VSVG) at a MOI of 2 (Figure 4A). Three hours post-infection, the cells were washed to remove virus. Infected cells were then subjected to different culture conditions. Between 3 and 24 h post infection, cells were cultured either 1) without anti-CD3; 2) with anti-CD3; 3) with anti-CD3 for a specified period of time before removal of anti-CD3; or 4) off anti-CD3 for a specified period of time before being placed on anti-CD3. IL-2 was maintained in all culture conditions. At 24 h post-infection, the cells were transferred to a new well with mIL-2 alone. Cells were cultured for an additional 24 h before analysis by flow cytometry for infection efficiency.
###end p 29
###begin title 30
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
Signals from CD3 are important for HIV-1 infection in activated primary mouse T cells.
###end title 30
###begin p 31
###xml 65 66 65 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 65 66 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>+</sup></italic>
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>&#8722;</sup></italic>
###xml 750 751 750 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1021 1022 1021 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1736 1737 1736 1737 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2106 2115 2106 2115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g002">Figure 2B</xref>
###xml 2124 2125 2124 2125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2440 2461 2440 2461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 2509 2510 2509 2510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2524 2528 2524 2528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wasp</italic>
###xml 2528 2531 2528 2531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2533 2541 2533 2537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pkc&#952;</italic>
###xml 2541 2544 2537 2540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2549 2555 2545 2551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Carma1</italic>
###xml 2555 2558 2551 2554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 164 167 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 776 791 <span type="species:ncbi:10090">transgenic mice</span>
###xml 862 867 <span type="species:ncbi:10090">mouse</span>
###xml 1070 1074 <span type="species:ncbi:10090">mice</span>
###xml 1094 1097 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1098 1101 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1509 1513 <span type="species:ncbi:10090">mice</span>
###xml 1762 1777 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1797 1800 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 2150 2165 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2185 2188 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 2559 2563 <span type="species:ncbi:10090">mice</span>
###xml 2652 2655 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 2656 2659 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The scheme for this experiment is shown in (A). MACS purified CD4+ CD25- T cells were activated by anti-CD3/28 for 36 h before spin-infection with VSVG-pseudotyped HIV-GFP. Infected cells were then subjected to different culture conditions. Between 3 and 24 h post infection, cells were cultured either A1) without anti-CD3; A2) with anti-CD3; A3) with anti-CD3 for a specified period of time before removal of anti-CD3; or A4) off anti-CD3 for a specified period of time before being placed on anti-CD3. Filled bars show the presence of anti-CD3 while open bars show the absence. At 24 h post infection, all cells were cultured with mIL-2 alone. Infection was assessed by GFP expression using flow cytometry at 48 h post-infection. (B) Activated CD4+ T cells from hCyclin T1 transgenic mice were subjected to the analysis shown in panel A condition 3. Infected mouse T cells were incubated on anti-CD3/28 antibody first and then removed from antibody at different time point as indicated on the x-axis. (C) Activated CD4+ T cells from wild type C57/BL6 (B6) and Balb/c mice were infected with HIV-CMV-GFP (VSVG) at MOI of 2. After infection, cells were provided with anti-CD3/28 (black bar), anti-CD3 (grey bar) or no antibody (open bar). (D) Analysis was as in panel A condition 2, except that PMA and ionomycin were used in place of anti-CD3. (E) Analysis was done as in panel B except that MLV was used. (F) Analysis as in panel in panel A condition 4. At 3 h or 6 h post-infection, cells from hCyclin T1 mice were transferred to wells without anti-CD3. At 12 h or 15 h post-infection, these cells were transferred back to wells with anti-CD3. As controls, cells were treated under condition A1 and A2 at 3 h post infection. (G) CD4+ T cells from hCyclin T1 transgenic mice were infected with HIV-GFP (VSVG). Cells were taken off anti-CD3/28 at 3 h post-infection and transferred to wells without or with anti-CD3 as in panel A conditions A1 and A2. At different time points indicated on the X-axis, cells were collected and subjected to Real Time-PCR specific for U5-Gag as described in the legend to Figure 2B. (H) CD4+ T cells from hCyclin T1 transgenic mice were infected with HIV-GFP (VSVG). Cells were taken off anti-CD3/28 at 3 h post-infection and transferred to wells without or with anti-CD3 as in panel A conditions A1 and A2. At two days post infection, cells were collected and subjected to two-round PCRs, as described in Materials and Methods, to quantify the integrated proviruses. (I) CD4+ T cells from Wasp-/-, Pkctheta-/- and Carma1-/- mice were activated with anti-CD3/28 in the presence of 100 U/ml mIL-2. After infection with HIV-CMV-GFP (VSVG), cells were provided with secondary anti-CD3 or no antibody as shown as in panel A conditions 1 and 2. All data represented three independent experiments.
###end p 31
###begin p 32
###xml 136 145 136 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Figure 4B</xref>
###xml 369 378 369 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Figure 4B</xref>
###xml 571 580 571 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Figure 4C</xref>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
###xml 121 124 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 545 550 <span type="species:ncbi:10090">mouse</span>
HIV-1 infection efficiency in primary mouse T cells correlated well with the duration of secondary TCR stimulation after HIV infection (Figure 4B). Only 2% of cells were infected if the cells were removed from antibody at 3 h post-infection. Infection level increased linearly with the incubation time on plate-bound antibodies and reached a maximum of 25% after 24 h (Figure 4B). The infection efficiency did not increase further if cells were stimulated beyond this 24 h window (data not shown). Addition of anti-CD28 did not further increase mouse T cell infectivity (Figure 4C)
###end p 32
###begin p 33
###xml 268 271 268 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gfp</italic>
###xml 281 284 281 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 470 479 470 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Figure 4C</xref>
###xml 740 741 740 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 740 741 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>+</sup></italic>
###xml 1138 1147 1138 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Figure 4D</xref>
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 78 93 <span type="species:ncbi:10090">transgenic mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 205 210 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 247 250 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 304 307 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 308 311 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 340 343 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 388 403 <span type="species:ncbi:10090">transgenic mice</span>
###xml 443 448 <span type="species:ncbi:10090">mouse</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
###xml 643 658 <span type="species:ncbi:10090">transgenic mice</span>
###xml 695 700 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 854 859 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 974 977 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 991 996 <span type="species:ncbi:10090">Mouse</span>
###xml 1059 1064 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The effect of secondary stimulation was initially observed in human cyclin T1 transgenic mice. To determine if the activation signals were also necessary in primary T cells from wild type mice, we used an HIV-1 construct in which Cytomegalovirus (CMV) promoter-driven gfp replaced nef. While this virus (HIV-CMV-GFP) gave similar result to HIV-GFP virus in primary T cells from hCyclinT1 transgenic mice, it bypassed the need for hCylin T1 in mouse T cells. As shown in Figure 4C, in wild type B6 or Balb/c mice activation signals were also necessary for maximum infection, although this was lower than observed in the mixed background of the transgenic mice. Removal of anti-CD3 and CD28 after HIV-1 infection reduced the percentage of GFP+ T cells 5-10-fold to 0.5-1%. Treatment with anti-CD28 or IL-2 was neither necessary nor sufficient for enhanced HIV-1 infection. We further tested if phorbol myristate acetate (PMA) and ionomycin could replace anti-CD3 in promoting HIV replication. Mouse T cells were pre-activated with anti-CD3 and anti-CD28. After HIV-1 infection, PMA and ionomycin were added instead of anti-CD3. As shown in Figure 4D, treatment with PMA alone fully recapitulated the role of anti-CD3.
###end p 33
###begin p 34
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 226 235 226 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Figure 4E</xref>
###xml 347 356 347 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Figure 4E</xref>
###xml 58 63 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
###xml 416 422 <span type="species:ncbi:10090">murine</span>
###xml 449 454 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 513 518 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To determine if the effect of TCR signaling was unique to HIV-1, we treated mouse CD4+ T cells in the same way during infection with MLV. At high MOI, infection efficiency was similar with or without the secondary TCR signal (Figure 4E). At low MOI, removal of the anti-CD3 antibody at 3 h post-infection resulted in a 50% reduction in infection (Figure 4E). The secondary TCR signal therefore enhances infection of murine T cells with both MLV and HIV-1, but appears to have a greater effect upon infection with HIV-1.
###end p 34
###begin p 35
###xml 263 270 263 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Fig. 4A</xref>
###xml 503 512 503 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Figure 4F</xref>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
To further characterize the requirement for TCR signaling, we infected activated mouse T cells and re-plated them without anti-CD3 stimulation. At the peak of reverse transcription (12 to 15 h post-infection), we re-plated the cells on anti-CD3 (condition (4) in Fig. 4A). Antibody was removed at 24 h post infection and cells were assayed at 48 h post-infection. Under these conditions, 70-80% of the maximum infection efficiency was obtained, as compared to 7-10% if CD3 stimulation was not provided (Figure 4F).
###end p 35
###begin p 36
###xml 268 277 268 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Figure 4G</xref>
###xml 542 546 542 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Greger1">[34]</xref>
###xml 548 552 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Ha1">[35]</xref>
###xml 713 722 713 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Figure 4H</xref>
###xml 1140 1150 1140 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Discussion</xref>
###xml 1282 1286 1282 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-OswaldRichter1">[36]</xref>
###xml 32 35 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 510 515 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 612 617 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 941 946 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1249 1254 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1268 1273 <span type="species:ncbi:9606">human</span>
###xml 1336 1341 <span type="species:ncbi:10090">mouse</span>
###xml 1374 1377 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
To establish which stage of the HIV replication cycle was enhanced by TCR signaling, we analyzed reverse transcription under the various stimulation conditions. Late reverse transcription products were decreased about 2-3 fold in the absence of secondary stimulation (Figure 4G), but the reduction was more modest than the 10-fold effect in infection efficiency. To measure the difference in integrated provirus, a two round amplification strategy was employed, with the first round using primers specific for HIV-1 Gag and SINE B2 sequences [34], [35] and the second round using primers and probes specific for HIV-1 U5. Integrated provirus levels were reduced 5-8 fold in the absence of a secondary TCR signal (Figure 4H). As pre-activated T cells are actively engaged in cell proliferation (at least once per 24 h) and we did not find consistent down-regulation of 2-LTR circles (data not shown), we do not believe that nuclear import of HIV-1 DNA was affected in the absence of the secondary TCR signal. These results suggest that the activation signals are important for both reverse transcription and other pre-integration steps (see Discussion). It has been reported that duration of anti-CD3/28 and IL-2 signaling is important for efficient HIV-1 infection of human T cells [36]. Our results indicate that activation of primary mouse T cells prior to infection with HIV is not sufficient for viral replication, and that secondary TCR signals are required for post-entry events.
###end p 36
###begin p 37
###xml 266 267 258 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 443 452 431 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Figure 4I</xref>
###xml 769 773 753 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Huang1">[37]</xref>
###xml 843 852 827 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Figure 4I</xref>
###xml 221 224 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 379 384 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 521 526 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 837 841 <span type="species:ncbi:10090">mice</span>
###xml 902 907 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Ligation of the TCR/CD3 complex activates several distinct signaling pathways, including the NF-kappaB pathway that is dependent on PKC-theta and CARMA1. To determine whether this pathway has a role in promoting steps in HIV replication, we examined infection of CD4+ T cells from mice deficient in PKC-theta or CARMA1. Primary T cells from both strains of mutant mice supported HIV-1 infection as long as secondary TCR signals were provided (Figure 4I). Thus, signaling pathways involved in efficient integration of the HIV-1 provirus are independent of these upstream effectors of NF-kappaB activation. Wiskott-Aldrich Syndrome protein (WASp)-mediated cytoskeleton reorganization is another pathway downstream of the TCR and is important for immune synapse formation [37]. We obtained a similar result with T cells from WASp-deficient mice (Figure 4I) indicating that this pathway is not involved in HIV-1 replication.
###end p 37
###begin title 38
###xml 39 44 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
The role of secondary TCR signaling in HIV-1 infection is specific for primary mouse T cells
###end title 38
###begin p 39
###xml 326 335 326 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g005">Figure 5A</xref>
###xml 68 73 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
###xml 118 123 <span type="species:ncbi:9606">human</span>
###xml 157 162 <span type="species:ncbi:10090">mouse</span>
###xml 185 190 <span type="species:ncbi:10090">mouse</span>
###xml 224 227 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 228 231 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 384 389 <span type="species:ncbi:10090">mouse</span>
We wished to determine whether a secondary TCR signal also promotes HIV-1 infection of mouse T cell lines and primary human T cells, as it does with primary mouse T cells. Infection of mouse T cell lines 1010-5 and AKR with HIV-CMV-GFP (VSVG) at MOI of 2 did not require the secondary TCR signals provided by anti-CD3 or PMA (Figure 5A). Similar results were obtained using two other mouse T cell lines (TA3 or 166, data not shown).
###end p 39
###begin title 40
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Role of secondary TCR signals is specific for mouse primary T cells.
###end title 40
###begin p 41
###xml 338 339 338 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 438 459 438 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 57 60 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 61 64 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 357 362 <span type="species:ncbi:9606">human</span>
(A) mouse T cell lines 1010-5 and AKR were infected with HIV-CMV-GFP (VSVG) at MOI of 2. Three hours post infection, cells were transferred to wells with coated anti-CD3, no antibody, or PMA. Twenty-four hours post infection, cells were transferred to new wells with IL-2 alone. FACS analysis for GFP was done 48 h post infection. (B) CD4+ T cells from two human cord blood donors were activated with anti-CD3/28 for 36 h as described in Materials and Methods. Cells were infected and analyzed as in panel A.
###end p 41
###begin p 42
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 270 279 270 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g005">Figure 5B</xref>
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 100 105 <span type="species:ncbi:9606">human</span>
###xml 161 166 <span type="species:ncbi:10090">mouse</span>
###xml 206 211 <span type="species:ncbi:9606">human</span>
###xml 360 365 <span type="species:ncbi:9606">human</span>
###xml 445 450 <span type="species:ncbi:9606">human</span>
The majority of mouse T cells from 6-8 week old mice are naive whereas the majority of T cells from human PBMCs are memory T cells. For a better comparison with mouse T cells, we isolated CD4+ T cells from human cord blood, as most of these cells are naive. As shown in Figure 5B, secondary treatment with PMA or anti-CD3 had no effect on infection of primary human T cells. In addition, we obtained similar results when total CD4+ T cells from human PBMCs were used (data not shown).
###end p 42
###begin title 43
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
CsA further relieves the pre-integration block in primary mouse T cells
###end title 43
###begin p 44
###xml 197 206 189 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g006">Figure 6A</xref>
###xml 309 318 301 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g006">Figure 6B</xref>
###xml 459 463 451 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wasp</italic>
###xml 463 466 455 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 471 479 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pkc&#952;</italic>
###xml 479 482 467 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 501 510 489 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g006">Figure 6C</xref>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
###xml 632 637 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In the course of our experiments, we found that Cyclosporin A, when added 3 h post-infection, increased infection efficiency from 21% (DMSO) to 35% at 0.1 microg/ml CsA and 42% at 1 microg/ml CsA (Figure 6A). However, CsA could not substitute for TCR signals, but instead amplified the effect of TCR signals (Figure 6B). In the absence of TCR signals, CsA only modestly increased the infection efficiency from 2% to 5%. We further tested the effect of CsA on Wasp-/- and Pkctheta-/- mice. As shown in Figure 6C, the TCR signaling pathways that require these proteins are not involved in the mechanism of CsA mediated enhancement of HIV-1 infection.
###end p 44
###begin title 45
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
CsA further sensitizes the TCR effect on the pre-integration block in mouse T cells.
###end title 45
###begin p 46
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 580 581 568 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 606 614 594 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pkc&#952;</italic>
###xml 614 617 598 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 622 626 606 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wasp</italic>
###xml 626 629 610 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 33 48 <span type="species:ncbi:10090">transgenic mice</span>
###xml 82 85 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 668 671 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 672 675 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
(A) CD4+ T cells from hCyclin T1 transgenic mice were activated and infected with HIV-GFP (VSVG). Three hours post infection, cells were transferred to wells coated with anti-CD3 together with 0.1 microg/ml CsA, 1 microg/ml CsA or DMSO control. Twenty-four hours post infection, cells were washed twice with PBS and transferred to new wells with IL-2 alone. FACS analysis for GFP was done 48 h post infection. (B) Analysis was as in panel A except that at 3 h post infection cells were transferred to wells coated with or without anti-CD3, together with 0.1 microg/ml CsA. (C) CD4+ T cells from wild type, Pkctheta-/- and Wasp-/- mice were activated and infected with HIV-CMV-GFP (VSVG). Three hours post infection, cells were transferred to wells coated with anti-CD3, together with 0.1 microg/ml CsA, Cells were then analyzed as in panel A.
###end p 46
###begin title 47
###xml 32 47 <span type="species:ncbi:10090">transgenic mice</span>
###xml 64 69 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Primary T cells from hCyclin T1 transgenic mice have defects in HIV-1 transcription and translation
###end title 47
###begin p 48
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Sun1">[12]</xref>
###xml 777 786 777 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g007">Figure 7A</xref>
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
###xml 134 139 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 218 223 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 239 244 <span type="species:ncbi:10090">mouse</span>
###xml 278 281 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 444 459 <span type="species:ncbi:10090">transgenic mice</span>
###xml 581 586 <span type="species:ncbi:10090">mouse</span>
###xml 635 640 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 694 699 <span type="species:ncbi:9606">human</span>
###xml 817 822 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 824 828 <span type="species:ncbi:11676">VSVG</span>
###xml 855 860 <span type="species:ncbi:10090">mouse</span>
###xml 865 870 <span type="species:ncbi:9606">human</span>
###xml 951 956 <span type="species:ncbi:9606">human</span>
###xml 961 966 <span type="species:ncbi:10090">mouse</span>
###xml 1038 1043 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1075 1080 <span type="species:ncbi:9606">human</span>
###xml 1094 1099 <span type="species:ncbi:10090">mouse</span>
The relief of the pre-integration block in primary mouse T cells enabled us to further characterize the post-integration steps in the HIV-1 replication cycle. The expression of hCyclin T1 enhances the transcription of HIV-1 RNA in primary mouse T cells [12]. When infected with HIV-GFP (VSVG), in which GFP is driven by the LTR promoter, there were very few detectable GFP positive T cells in wild type mice as compared to 15-25% in hCyclin T1 transgenic mice (data not shown). To establish whether the expression of hCyclin T1 was sufficient to relieve the transcription block in mouse T cells, we further analyzed the level of total HIV-1 RNAs in hCyclin T1 transgenic T cells as compared to human T cells by real-time PCR using primers specific for U5 sequences in the LTR (Figure 7A). Single round infection with HIV-1 (VSVG) was performed in primary mouse and human T cells. The U5 RNAs were normalized to the 18S rRNA and compared between total human and mouse cells. After normalization to infection efficiency, about 10 fold more HIV-1 RNAs were detected in infected human T cells than mouse T cells.
###end p 48
###begin title 49
###xml 12 17 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Analysis of HIV-1 RNA and proteins in infected primary mouse T cells.
###end title 49
###begin p 50
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 86 90 <span type="species:ncbi:11676">VSVG</span>
###xml 103 106 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 542 545 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 561 564 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 661 664 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 699 703 <span type="species:ncbi:10090">mice</span>
###xml 755 760 <span type="species:ncbi:9606">human</span>
###xml 1085 1088 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1094 1098 <span type="species:ncbi:11676">VSVG</span>
Primary CD4+ T cells from hCyclin T1 mice (mT) or human PBMCs (hT) were infected with VSVG-pseudotyped HIV-GFP at MOI of 2 in the presence or absence of AZT. Forty-eight hours later, cells were collected. (A) Total RNA was extracted from infected cells. Infection in the presence of AZT served as negative control for de novo expression of RNA. cDNA formation in the absence of reverse transcription enzyme served as negative control for contaminating DNA. Real Time-PCR was performed using primers and probes specific for 18S rRNA and R-U5 (HIV). The ratio of HIV to 18S rRNA was further normalized by infection efficiency to show the relative copy numbers of HIV RNAs per infected cell. hCyclinT1 mice gave an average of 20% infection efficiency, while human T cells gave an average of 50%. (B) Total cellular proteins were analyzed on 12% acrylamide gels and subjected to western blot analysis with anti-p24 monoclonal antibody. Endogenous alpha-tubulin was analyzed on the same membrane as a loading control. As a comparison, stable clones derived from 3T3/Cyclin T1 infected with HIV-GFP (VSVG) were analyzed in parallel.
###end p 50
###begin p 51
###xml 148 157 148 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g007">Figure 7B</xref>
###xml 295 304 295 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g008">Figure 8A</xref>
###xml 336 345 336 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g007">Figure 7B</xref>
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 71 76 <span type="species:ncbi:9606">Human</span>
###xml 163 168 <span type="species:ncbi:10090">mouse</span>
###xml 280 285 <span type="species:ncbi:9606">human</span>
Subsequent steps in the HIV-1 replication cycle were further examined. Human T cells express full-length Gag proteins and efficiently process them (Figure 7B). In mouse T cells infected with an efficiency of 20-25%, expression of Gag was reduced approximately 70-fold compared to human T cells (Figure 8A) and Gag remained unprocessed (Figure 7B).
###end p 51
###begin title 52
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Primary CD4+ T cells from hCyclin T1 mice do not release virus efficiently.
###end title 52
###begin p 53
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 19 20 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 258 278 258 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Material and Methods</xref>
###xml 493 494 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 48 52 <span type="species:ncbi:11676">VSVG</span>
###xml 65 68 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 484 489 <span type="species:ncbi:9606">human</span>
###xml 599 602 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 608 612 <span type="species:ncbi:11676">VSVG</span>
###xml 681 685 <span type="species:ncbi:11676">VSVG</span>
###xml 1064 1069 <span type="species:ncbi:9606">human</span>
###xml 1085 1089 <span type="species:ncbi:10090">mice</span>
Activated CD4+ CD25- T cells were infected with VSVG-pseudotyped HIV-GFP or JRCSF at MOI of 2. Three hours post-infection, cells were washed and plated on anti-CD3 with mIL-2. Twenty-four hours post-infection, cells were treated with pronase as described in Material and Methods. Infected cells were incubated at 37degreesC for an additional 24 h and checked by flow cytometry to assess viability. Cells and supernatants were collected after centrifugation. For comparison, activated human CD4+ T cells were analyzed in parallel. (A) p24 levels in cell lysates and supernatants after infection with HIV-GFP (VSVG). (B) Infectivity of virus released from cells infected with JRCSF (VSVG) was measured by adding supernatant to Tzmbl reporter cell lines. At 16 h after infection, AZT and TAK-779 were added to Tzmbl to prevent a second round of infection. Firefly luciferase assays were performed at 48 h post-infection. Luciferase signals in mock infection control were subtracted from those in infected cells. The data represented experiments using cells from five human donors or five mice. p24 levels in the supernatant (by ELISA) were used for normalization.
###end p 53
###begin title 54
###xml 32 47 <span type="species:ncbi:10090">transgenic mice</span>
Primary T cells from hCyclin T1 transgenic mice have defects in virus release and infectivity
###end title 54
###begin p 55
###xml 158 159 158 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 248 249 248 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 797 798 797 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 839 840 839 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 839 840 839 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>+</sup></italic>
###xml 1035 1044 1035 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g008">Figure 8A</xref>
###xml 93 96 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
###xml 116 121 <span type="species:ncbi:9606">human</span>
###xml 215 218 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 224 228 <span type="species:ncbi:11676">VSVG</span>
###xml 239 244 <span type="species:ncbi:10090">mouse</span>
###xml 799 804 <span type="species:ncbi:10090">mouse</span>
###xml 882 887 <span type="species:ncbi:10090">mouse</span>
###xml 911 916 <span type="species:ncbi:9606">human</span>
###xml 991 996 <span type="species:ncbi:10090">mouse</span>
###xml 1020 1025 <span type="species:ncbi:9606">human</span>
To measure the efficiency of p24 release, the ratio of extracellular to intracellular p24 in HIV-infected mouse and human T cells was determined by ELISA. CD4+ T cells were activated for 36 h and spin infected with HIV-GFP (VSVG). Because mouse CD4+ T cells express and release low levels of p24, small amounts of residual input virus can lead to a false signal of viral release. To avoid this contaminating signal, the cells were treated with pronase to remove virus bound to the outside of the cell after infection. Additionally, cell death could lead to release of p24 into the medium, so cell viability was carefully monitored. We excluded any experiments in which there were fewer than 70-80% live cells at 2 d post infection. We could consistently achieve this when using highly purified CD4+ mouse T cells that were depleted of CD25+ cells. The release of p24 was reduced in mouse T cells as compared to human cells. The ratio of extracellular to intracellular p24 averaged 0.015 for mouse T cells versus 0.4 for human T cells (Figure 8A).
###end p 55
###begin p 56
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Derdeyn1">[38]</xref>
###xml 483 492 483 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g008">Figure 8B</xref>
###xml 159 164 <span type="species:ncbi:10090">Mouse</span>
###xml 169 174 <span type="species:ncbi:9606">human</span>
###xml 209 213 <span type="species:ncbi:11676">VSVG</span>
###xml 269 274 <span type="species:ncbi:10090">Mouse</span>
###xml 333 338 <span type="species:ncbi:9606">human</span>
###xml 409 414 <span type="species:ncbi:10090">mouse</span>
###xml 468 473 <span type="species:ncbi:9606">human</span>
To measure virus infectivity, we used a reporter cell line (Tzmbl), which is a HeLa cell line stably transfected with LTR-luciferase and hCD4/CXCR4/CCR5 [38]. Mouse and human T cells were infected with JRCSF (VSVG) and the supernatants were used to infect Tzmbl cells. Mouse T cells released 300-500-fold lower infectious virus than human T cells. After normalization to the level of p24, virus released from mouse cells had 6-10 fold lower infectivity than that from human T cells (Figure 8B).
###end p 56
###begin title 57
###xml 32 47 <span type="species:ncbi:10090">transgenic mice</span>
Primary T cells from hCyclin T1 transgenic mice have a defect in virus budding
###end title 57
###begin p 58
###xml 222 230 222 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g009">Figure 9</xref>
###xml 36 39 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 117 122 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 207 212 <span type="species:ncbi:9606">human</span>
To view the assembly and budding of HIV, electron microscopy was performed for mouse and human T cells infected with HIV-1. The process of virus budding and release can be observed at the plasma membrane in human T cells (Figure 9, upper panels). Interestingly, viruses were not released from the entire plasma membrane. Instead, release was localized to a few discrete areas. Virus budding through the multi-vesicular body (MVB) was not detected.
###end p 58
###begin title 59
###xml 27 30 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 40 45 <span type="species:ncbi:10090">mouse</span>
Defective virus budding in HIV infected mouse T cells.
###end title 59
###begin p 60
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
###xml 208 213 <span type="species:ncbi:10090">mouse</span>
Electron microscopy of infected human (upper panel) and mouse (lower panel) T cells. On the left, low magnification of infected cells; in the middle, higher magnification of infected cells; on the right (for mouse T cells), aberrant budding of VLP into nuclear membranes is shown. Red arrows indicate assembling viral particles, while blue arrows indicate inner and outer nuclear membranes.
###end p 60
###begin p 61
###xml 73 81 73 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g009">Figure 9</xref>
###xml 271 279 271 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g009">Figure 9</xref>
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
No virus was detected budding from the plasma membrane in mouse T cells (Figure 9, lower panels), but some particles were observed budding into the nuclear membrane. In other cells, viruses were observed to assemble and bud randomly into or from intracellular membranes (Figure 9, lower panels).
###end p 61
###begin title 62
Discussion
###end title 62
###begin p 63
###xml 16 21 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
###xml 136 141 <span type="species:ncbi:9606">human</span>
###xml 194 199 <span type="species:ncbi:10090">mouse</span>
###xml 229 232 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 388 393 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 472 477 <span type="species:ncbi:10090">mouse</span>
###xml 555 560 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We have studied HIV-1 replication in primary mouse T cells and compared the efficiency of each step in mouse cells with that in primary human T cells. Expression of hCD4, CCR5 and hCyclin T1 in mouse T cells removed the block to HIV entry and greatly enhanced viral transcription. In this study, we relieved the block prior to integration by providing TCR signals and Cyclosporin A after HIV-1 infection. However, multiple additional blocks were found to exist in primary mouse T cells. These blocks together prohibit release of high titers of infectious HIV-1 sufficient for virus spreading.
###end p 63
###begin title 64
Virus Entry
###end title 64
###begin p 65
###xml 75 78 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD4</italic>
###xml 152 153 152 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 443 444 443 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 555 559 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Sundrud1">[39]</xref>
###xml 143 148 <span type="species:ncbi:10090">mouse</span>
###xml 202 217 <span type="species:ncbi:10090">transgenic mice</span>
###xml 299 304 <span type="species:ncbi:10090">mouse</span>
###xml 434 439 <span type="species:ncbi:10090">mouse</span>
###xml 469 474 <span type="species:ncbi:9606">human</span>
###xml 582 587 <span type="species:ncbi:10090">mouse</span>
###xml 620 625 <span type="species:ncbi:9606">human</span>
###xml 741 746 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
Transgenic constructs containing enhancers, promoter, and silencer of the hCD4 gene enable high expression of hCD4 and hCCR5 on the surface of mouse CD4+ T cells, macrophages and dendritic cells in the transgenic mice used in this study. There are very few cells that are hCD4 or hCCR5 positive but mouse CD4 negative (Data not shown). While this is a good system to study virus entry, CCR5 is expressed at a much higher level on all mouse CD4+ T cells, in contrast to human T cells, in which it is expressed primarily on memory rather than naive T cells [39]. Thus, the transgenic mouse cells were more permissive than human cells for virus entry. This transgenic model may hence lead to more severe T cell depletion if the other blocks to HIV-1 replication can be solved, and a better model to use may be hCCR5 knock-in mice.
###end p 65
###begin p 66
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Carroll1">[40]</xref>
###xml 513 520 513 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 684 688 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Zack1">[41]</xref>
###xml 690 694 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Zhou1">[42]</xref>
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 223 228 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 257 262 <span type="species:ncbi:10090">mouse</span>
###xml 451 456 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 472 477 <span type="species:ncbi:10090">mouse</span>
###xml 524 529 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 624 627 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 857 862 <span type="species:ncbi:9606">human</span>
The expression level of hCCR5 was down regulated by activation using coated anti-CD3/28 antibodies. This is consistent with previous studies showing that anti-CD28 down-regulates CCR5 in human T cells, inhibiting R5 tropic HIV-1 infection [40]. However, in mouse cells, degradation rather than synthesis of CCR5 RNA may be affected, as hCCR5 expression was not driven by the endogenous promoter. CCR5 down-regulation resulted in reduction in entry of HIV-1 into activated mouse T cells. This may not be a problem in vivo as HIV-1 can enter resting cells, in which reverse transcription is initiated. Subsequent steps of the HIV life cycle can then be completed upon T cell activation [41], [42]. We also note that hCCR5 staining with antibody did not correlate well with the efficiency of hCCR5 mediated virus entry. For example, a much lower percentage of human T cells can be stained with hCCR5 antibody, while they supported 30% of virus entry. This could be due to the need for few hCCR5 molecules to obtain virus entry.
###end p 66
###begin title 67
Reverse Transcription
###end title 67
###begin p 68
###xml 540 544 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Tsurutani1">[43]</xref>
###xml 634 638 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Baumann1">[25]</xref>
###xml 6 11 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 29 33 <span type="species:ncbi:11676">VSVG</span>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
###xml 66 71 <span type="species:ncbi:9606">human</span>
###xml 95 100 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 395 400 <span type="species:ncbi:10090">mouse</span>
###xml 526 531 <span type="species:ncbi:10090">mouse</span>
###xml 615 620 <span type="species:ncbi:10090">mouse</span>
###xml 700 705 <span type="species:ncbi:10090">mouse</span>
###xml 792 797 <span type="species:ncbi:10090">mouse</span>
Using HIV-1 pseudotyped with VSVG to normalize entry in mouse and human T cells, we found that HIV-1 reverse transcription had the same kinetics in the two species. Reverse transcription products peaked around 12-15 h, which was followed by down-regulation of virus DNA induced by an unknown mechanism. From these data, we are able to conclude that there is no block to reverse transcription in mouse cells. These conclusions are supported by a recent publication which also found no block to reverse transcription in primary mouse T cells [43]. However, reduction of reverse transcription products was observed in mouse T cell lines [25]. This may be because of the use of high MOI of viruses or if mouse T cell lines behave differently from primary T cells. The differences between primary mouse T cells and T cell lines may be due to genetic background or to transcriptional changes that occurred upon transformation.
###end p 68
###begin title 69
Nuclear import and integration
###end title 69
###begin p 70
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-ODoherty1">[44]</xref>
###xml 1177 1181 1177 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Bieniasz1">[15]</xref>
###xml 1183 1187 1183 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Mariani1">[16]</xref>
###xml 44 47 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
###xml 67 72 <span type="species:ncbi:9606">human</span>
###xml 202 207 <span type="species:ncbi:10090">mouse</span>
###xml 212 217 <span type="species:ncbi:9606">human</span>
###xml 260 265 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 465 468 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 526 531 <span type="species:ncbi:9606">human</span>
###xml 692 697 <span type="species:ncbi:10090">mouse</span>
###xml 778 783 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 802 807 <span type="species:ncbi:10090">mouse</span>
###xml 830 835 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 979 984 <span type="species:ncbi:10090">mouse</span>
###xml 989 994 <span type="species:ncbi:9606">human</span>
###xml 1019 1022 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1142 1145 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We found similar levels of 2-LTR circles in HIV-infected mouse and human T cells, consistent with equivalent nuclear import of preintegration complexes. Integration is more difficult to compare between mouse and human cells. One way to quantify integration of HIV-1 is to separate genomic from small molecular weight DNA and quantify the integrated provirus. This experiment needs to be carefully controlled since a small amount of contamination with un-integrated HIV DNA can influence the results. To measure integration in human cells, many groups have taken advantage of the abundant Alu sequences which are found, on average, every 500bp throughout the genome [44]. SINE B2 sequences in mouse cells are less frequent; however, they can be used to compare the efficiency of HIV-1 integration among mouse cell samples. Because HIV-1 integration cannot be quantitatively compared between species by using these methods, we have chosen to compare integration efficiency between mouse and human by infecting cells with HIV-GFP and using GFP expression as a surrogate marker for integration, an approach used previously to study blocks in the HIV replication cycle in 3T3 cells [15], [16].
###end p 70
###begin p 71
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Berthoux1">[26]</xref>
###xml 469 473 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Sokolskaja1">[27]</xref>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Towers1">[28]</xref>
###xml 561 565 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Sokolskaja2">[45]</xref>
###xml 805 809 801 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Berthoux1">[26]</xref>
###xml 811 815 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Sokolskaja1">[27]</xref>
###xml 817 821 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Towers1">[28]</xref>
###xml 978 982 974 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Noser1">[46]</xref>
###xml 1129 1138 1125 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g006">Figure 6B</xref>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 356 361 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 407 412 <span type="species:ncbi:9606">human</span>
###xml 570 575 <span type="species:ncbi:9606">human</span>
###xml 675 685 <span type="species:ncbi:9505">owl monkey</span>
###xml 729 734 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 903 908 <span type="species:ncbi:10090">mouse</span>
###xml 956 961 <span type="species:ncbi:10090">mouse</span>
###xml 1025 1030 <span type="species:ncbi:10090">mouse</span>
###xml 1203 1208 <span type="species:ncbi:9606">human</span>
###xml 1255 1260 <span type="species:ncbi:10090">mouse</span>
###xml 1283 1288 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1343 1346 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1437 1442 <span type="species:ncbi:10090">mouse</span>
###xml 1452 1457 <span type="species:ncbi:10090">Mouse</span>
We found that Cyclosporin A can double the infection efficiency of primary mouse T cells at a concentration that inhibits NFAT signaling. CsA probably works on steps after reverse transcription, since it had similar effect on cells treated between 12 h and 24 h post-infection (data not shown). It was reported that interruption of the interaction between HIV-1 CA and Cyclophilin A has opposite effects in human cells and non-permissive cells from other species [26], [27], [28]. Thus, CsA accentuated the restriction of Ref1 (Trim5alpha or other host factors [45]) in human cells, while greatly relieving the restriction of LV-1 in other species. For example, treatment of owl monkey cells with CsA increased the proportion of HIV-1 DNA in the nucleus and led to a 100-1000-fold increase in virus titer [26], [27], [28]. It was reported that Cyclosporin A enhanced the infection efficiency in primary mouse bone marrow cells but had no effect on primary mouse splenic T cells [46]. The failure to detect the enhancement in mouse T cells was likely due to the absence of TCR signals, which obscured the effect of Cyclosporin A (Figure 6B). We speculate that there is a mechanism similar to that in non-human primates, involving Cyclophilin A blockade of mouse T cell infection with HIV-1. It will be interesting to determine whether the G89V HIV mutant, whose CA cannot interact with Cyclophilin A, has a higher infection efficiency in mouse T cells. Mouse cells do not have a Trim5alpha ortholog, but other related proteins may be involved in this host restriction.
###end p 71
###begin title 72
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Activation signals for HIV-1 infection
###end title 72
###begin p 73
###xml 644 653 644 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Figure 4F</xref>
###xml 751 760 751 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Figure 4H</xref>
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
###xml 378 383 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 700 705 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 721 726 <span type="species:ncbi:10090">mouse</span>
###xml 832 835 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 903 906 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 957 960 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1037 1042 <span type="species:ncbi:10090">mouse</span>
###xml 1293 1298 <span type="species:ncbi:10090">mouse</span>
###xml 1303 1308 <span type="species:ncbi:9606">human</span>
In the process of optimizing conditions for HIV-1 infection of mouse T cells, we found that additional TCR signals were essential, in a limited time window, for infection of pre-activated T cells. In the absence of a secondary stimulus late reverse transcription products were decreased 2-3 fold. Although this suggests that TCR signals can enhance the reverse transcription of HIV-1, this is not likely to be the critical step affected, since providing TCR signals at the peak of reverse transcription did not result in a rebound of reverse transcription (data not shown), but rescued infection to an average of 70% of the maximum efficiency (Figure 4F). The TCR signals increased the efficiency of HIV-1 integration in mouse T cells about 5-8 fold (Figure 4H). It remains possible that TCR signals also affect steps subsequent to HIV integration. However, similar results were obtained using reporter HIV viruses whose GFP expression was driven by either CMV or LTR. Moreover, there was no change in GFP expression in infected primary mouse T cells when the secondary TCR signal was provided at 5 days instead of 3 hours post infection (data not shown). An accurate assessment will require a reliable technique that can quantify and compare levels of the integrated provirus between primary mouse and human T cells.
###end p 73
###begin p 74
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Tsurutani1">[43]</xref>
###xml 315 319 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Bieniasz1">[15]</xref>
###xml 321 326 321 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Mariani1">[16]]</xref>
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
###xml 86 101 <span type="species:ncbi:10090">transgenic mice</span>
###xml 204 209 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 284 289 <span type="species:ncbi:10090">mouse</span>
In a recent paper describing HIV-1 infection of primary mouse T cells from hCD4/CXCR4 transgenic mice, a significant pre-integration block was reported [43]. The block was ascribed to mis-localization of HIV-1 integrase protein from nucleus to the cytoplasm, but this was assessed in mouse 3T3 cells. We and others [15], [16]] have not observed a pre-integration block in 3T3 cells, suggesting that the localization of integrase protein is unrelated to successful nuclear import or integration. The major difference between our results and those in the recent paper most likely lies in the continued TCR stimulation that we employ, although it remains possible that there is an effect on integrase localization in the primary T cells.
###end p 74
###begin p 75
###xml 673 677 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Francois1">[47]</xref>
###xml 822 831 814 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002035.s003">Figure S3</xref>
###xml 940 944 932 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Cuenda1">[48]</xref>
###xml 1135 1139 1127 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Ariumi1">[49]</xref>
###xml 1141 1145 1133 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Daniel1">[50]</xref>
###xml 1147 1151 1139 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Daniel2">[51]</xref>
###xml 143 148 <span type="species:ncbi:10090">mouse</span>
###xml 159 164 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 418 421 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 556 559 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 731 736 <span type="species:ncbi:10090">mouse</span>
###xml 765 770 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1075 1080 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1289 1292 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1308 1314 <span type="species:ncbi:10090">murine</span>
Identification of the TCR signaling pathways involved in relieving the pre-integration blocks may provide further insight towards developing a mouse model for HIV-1 replication. It remains to be determined if antigen-presenting cell-T cell interaction is sufficient to provide the secondary TCR signals. Further experiments must be performed to establish which molecules downstream of the TCR can function to increase HIV infection. PKCtheta and CARMA1, which are required for NF-kappaB activation in T cells, as well as WASp are dispensable for efficient HIV infection after TCR stimulation. However, the PI3K-AKT pathway may be involved in promoting proviral integration [47]. PI3K inhibitor, added 1 h post-infection of primary mouse T cells, completely blocked HIV-1 infection in the presence of anti-CD3/28 and IL-2 (Figure S3). It is known that at different concentrations PI3K inhibitor can block both PI3K and its downstream kinase [48]. Additionally, PI3K is involved in DNA damage repair. Molecules involved in the DNA damage repair pathway have been implicated in HIV-1 integration, although these results are controversial [49], [50], [51]. Our preliminary results thus suggest that the PI3K/Akt, but not the NF-kappaB, pathway is important in facilitating post-entry steps of HIV replication in murine T cells.
###end p 75
###begin p 76
###xml 524 528 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Baumann1">[25]</xref>
###xml 639 648 639 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g004">Figure 4C</xref>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 214 219 <span type="species:ncbi:10090">mouse</span>
###xml 232 237 <span type="species:ncbi:10090">mouse</span>
###xml 412 417 <span type="species:ncbi:10090">mouse</span>
###xml 746 750 <span type="species:ncbi:10090">mice</span>
###xml 882 887 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 956 960 <span type="species:ncbi:10090">mice</span>
###xml 998 1001 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1083 1088 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The effect of secondary TCR signaling is not necessary for mouse T cell lines and primary human T cells. This implies that there is a species-specific factor(s) responsible for the pre-integration block in primary mouse T cells. In mouse cell lines, the TCR signals may have been bypassed upon transformation, and hence such stimulation has little effect. We note a much higher infection efficiency found in the mouse T cell lines used in this study, compared to another report indicating significant pre-integration blocks [25]. This may be due to the different genetic backgrounds between cell lines, similar to the observation shown in Figure 4C that primary cells from B6 and Balb/c are less infectable than cells from transgenic or knockout mice with mixed background. Further work needs to be done to identify the specific protein(s) involved in the TCR-dependent increase in HIV-1 infection. This may allow the generation of genetically manipulated mice that are permissive for single round HIV infection and may provide a better understanding of the pre-integration steps in HIV-1 infection.
###end p 76
###begin title 77
Virus release
###end title 77
###begin p 78
###xml 213 214 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Sun1">[12]</xref>
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Jamieson1">[52]</xref>
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Holm1">[53]</xref>
###xml 254 255 254 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 561 562 561 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 925 926 925 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 929 930 929 930 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1001 1002 1001 1002 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 68 73 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 74 89 <span type="species:ncbi:10090">transgenic mice</span>
###xml 175 178 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 271 274 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 275 290 <span type="species:ncbi:10090">transgenic mice</span>
###xml 457 472 <span type="species:ncbi:10090">transgenic mice</span>
###xml 490 495 <span type="species:ncbi:10090">mouse</span>
###xml 691 695 <span type="species:ncbi:11676">VSVG</span>
###xml 753 758 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 810 814 <span type="species:ncbi:11676">VSVG</span>
###xml 1070 1075 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1081 1086 <span type="species:ncbi:10090">mouse</span>
The last step of the HIV-1 life cycle is virus budding and release. HIV-1 transgenic mice can potentially be used to study this and other post-gene expression steps. However, HIV has been shown to be toxic for CD4+ T cells [12], [52], [53], so mature CD4+ T cells in the HIV transgenic mice have potentially undergone changes to allow them to survive. For this reason, we assessed particle maturation and release in freshly-infected T cells from hCyclin T1 transgenic mice. Because primary mouse T cells are very sensitive to apoptosis and activated primary CD4+ T cells are prone to activation-induced cell death, we used low viral MOI and optimized conditions to avoid cell death. We used VSVG-pseudotyped virus for these assays as the Env protein of HIV-1 was found to be more toxic to primary T cells than VSVG, as indicated by apoptosis analysis based on AnnexinV staining (data not shown). Additionally, removal of CD25+CD4+ regulatory T cells resulted in substantial increase in survival of CD4+ T cells. Under these conditions, we observed a block in release of HIV-1 from mouse cells.
###end p 78
###begin p 79
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 409 414 <span type="species:ncbi:10090">mouse</span>
###xml 479 484 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Compared to virus released from human T cells, virus released from primary mouse T cells was 6-10 fold less infectious. Compounding this reduced infectivity of released particles was the dramatic decrease in intracellular Gag. It is possible that viral restriction by host factors is more significant when virus production is low. We will have a better understanding of infectivity of particles released from mouse cells once we have improved the transcription and processing of HIV-1 Gag protein.
###end p 79
###begin p 80
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
###xml 145 150 <span type="species:ncbi:10090">mouse</span>
###xml 375 380 <span type="species:ncbi:9606">human</span>
Electron microscopy further confirmed the release block in mouse primary T cells. In these experiments, virus budding appeared to be abnormal in mouse T cells. We observed virus particle budding into the nuclear membrane and inducing swelling between the inner and outer nuclear membrane. We failed to observe virus budding out of the plasma membrane. This is in contrast to human cells where we easily observed viral release from the plasma membrane.
###end p 80
###begin p 81
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 105 110 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 243 248 <span type="species:ncbi:10090">mouse</span>
###xml 512 515 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
In conclusion, we have demonstrated that primary T cells from hCD4/CCR5/Cyclin T1 mice support efficient HIV-1 virus entry, reverse transcription and nuclear import. TCR signals were found to be essential to relieve a pre-integration block in mouse T cells, and this block was further relieved by CsA. The effect on proviral integration was confined to primary T cells, highlighting the importance of studying such cells in addition to immortalized cell lines in our efforts to acquire a better understanding of HIV replication. Our results also indicate that additional host factors wait to be identified to solve inefficient transcription, Gag translation, Gag processing and virus release.
###end p 81
###begin title 82
Materials and Methods
###end title 82
###begin title 83
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and Plasmids
###end title 83
###begin p 84
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Killeen1">[54]</xref>
###xml 235 238 235 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cd4</italic>
###xml 258 261 258 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD4</italic>
###xml 312 315 312 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Keppler1">[5]</xref>
###xml 317 321 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Sun1">[12]</xref>
###xml 605 624 605 624 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GAATACCGC GCGAAGCAT</named-content>
###xml 639 665 639 665 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCTTTTACGAG TAGAACTGGAAGAG</named-content>
###xml 921 924 921 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nef</italic>
###xml 952 956 952 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-He1">[55]</xref>
###xml 962 969 962 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-GFP</italic>
###xml 1085 1121 1085 1121 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ATAAGAATGCGGCCGCTTAATAGTAATCAATTACGG</named-content>
###xml 1132 1168 1132 1168 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCAGCTCGAGATTACTTGTACAGCTCGTCCATGCCG</named-content>
###xml 1394 1398 1391 1395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Wiskerchen1">[56]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 25 40 <span type="species:ncbi:10090">transgenic mice</span>
###xml 140 145 <span type="species:ncbi:9606">human</span>
###xml 176 181 <span type="species:ncbi:9606">human</span>
###xml 228 234 <span type="species:ncbi:10090">murine</span>
###xml 252 257 <span type="species:ncbi:9606">human</span>
###xml 351 366 <span type="species:ncbi:10090">transgenic mice</span>
###xml 410 415 <span type="species:ncbi:10090">mouse</span>
###xml 504 519 <span type="species:ncbi:10090">transgenic mice</span>
###xml 574 579 <span type="species:ncbi:10090">mouse</span>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
###xml 875 878 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 879 882 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 937 940 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 962 965 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1001 1004 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Human CD4/CCR5/Cyclin T1 transgenic mice were generated individually and bred into double or triple transgenic lines. Constructs included a human genomic CD4 minigene [54] and human CCR5 and Cyclin T1 cDNAs under the control of murine Cd4 enhancer and human CD4 promoter, silencer, and monocyte-lineage enhancer [5], [12]. Phenotype of hCD4 and hCCR5 transgenic mice was assessed by flow cytometry analysis of mouse blood stained with Pacific Blue-mCD4, APC-hCD4 and APC-Cy7-hCCR5 antibodies. hCyclin T1 transgenic mice were identified by PCR analysis of DNA extracted from mouse tails. Primers used were GAATACCGC GCGAAGCAT (forward) and CCTTTTACGAG TAGAACTGGAAGAG (reverse). Wild type Balb/c and C57BL6 mice were purchased from Taconic. All animal experiments were performed in accordance with approved protocols from the NYU Institutional Animal Care and Usage Committee. HIV-CMV-GFP plasmid was made by replacing the nef gene in the HIV-HSA vector [55] with CMV-GFP utilizing NotI and XhoI sites. CMV-GFP was amplified from pEGFP-C1 vector by PCR using primers as follows: forward ATAAGAATGCGGCCGCTTAATAGTAATCAATTACGG, reverse: CCAGCTCGAGATTACTTGTACAGCTCGTCCATGCCG. pM310 plasmid encoding Vpr-beta-lactamase was obtained from Michael D. Miller (Merck). R7/3-GFP and its D116A integrase mutant plasmids were obtained from Michael Topper and Mark Muesing (Aaron Diamond AIDS Research Center) [56]. Plasmid for 2-LTR circles was obtained from Mark Sharley (UMass).
###end p 84
###begin title 85
T cells
###end title 85
###begin p 86
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 365 366 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 568 569 568 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 995 996 995 996 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1266 1267 1255 1256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 551 556 <span type="species:ncbi:10090">mouse</span>
###xml 986 991 <span type="species:ncbi:10090">mouse</span>
###xml 1099 1103 <span type="species:ncbi:9913">Calf</span>
Human CD4+ T cells were purified from peripheral blood and cord blood obtained from the New York Blood Center. The blood procurement from healthy donors for this study has been reviewed and approved by the New York University School of Medicine Institutional Review Board. Mononuclear cells were isolated by Ficoll-Paque (GE Healthcare) gradient centrifugation. CD4+ T cells were further purified by positive selection using anti-hCD4 magnetic microbeads (1:20 dilution) and MACS column (Miltenyi Biotech), following the manufacturer's protocols. For mouse primary CD4+ T cells, single-cell suspensions from spleen and mesenteric lymph nodes were first enriched by staining with PE-conjugated anti-mCD8, mB220, mCD11b, mCD11c, mCD25 (all 1:100 dilution) and mTer119 (1:66 dilution), followed by incubation with anti-PE magnetic microbeads and depletion through MACS column. The depleted fraction was positively-selected by anti-mCD4 magnetic microbeads to get >99% pure resting primary mouse CD4+ T cells. T cells were cultured in RPMI 1640 (Invitrogen) supplemented with 10% heat-inactivated Fetal Calf Serum (Hyclone), 2 mM L-glutamine, 100 u/ml penicillin, 100 microg/ml streptomycin, and 50 microM beta-mercaptoethanol. Cells were plated at a density of 1-1.2x106 per well of a 24-well culture plate.
###end p 86
###begin title 87
Virus stocks
###end title 87
###begin p 88
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 421 422 413 414 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 838 847 814 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g003">Figure 3A</xref>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 135 138 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 144 147 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 148 151 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 221 225 <span type="species:ncbi:11676">VSVG</span>
HIV-1 stocks were generated by calcium phosphate transfection of 2.5x106 293T cells in 10 cm plate with 15 microg virus vector (JRCSF, HIV-GFP, HIV-CMV-GFP, R7/3-GFP or its D116A mutant) and 5 microg Env vector (JRCSF or VSVG) as indicated by envelope pseudotyping. Virus supernatants were collected 48 h post transfection and treated with Benzonase (15U/ml, EMD Bioscience) in 1x buffer (50 mM Tris-HCl pH 8.0, 1 mM MgCl2, and 0.1 mg/ml BSA) for 15 min at 37degreesC. Aliquots of virus were frozen at -80degreesC until use. Virus titer was determined by serial dilutions on GHOST/CCR5 or GHOST/parental cell lines in the presence of polybrene (8 microg/ml). R7/3 GFP and its D116A mutant viruses were also titrated with reverse transcriptase assay (RT assay kit, Roche) to ensure that similar amounts of virus were used for infection in Figure 3A for detecting 2LTR signals. Flow cytometry analysis was done 36 h after infection of GHOST cells to assess percentage of GFP positive cells. MLV was produced by transfection of Phoenix E cells with MSCV retrovirus vector expressing Cre-GFP. Titer was titrated on 3T3 cells.
###end p 88
###begin title 89
T cell activation and infections
###end title 89
###begin p 90
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 250 251 246 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 473 474 461 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1139 1140 1103 1104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1163 1171 1127 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pkc&#952;</italic>
###xml 1171 1174 1131 1134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1179 1185 1139 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Carma1</italic>
###xml 1185 1188 1145 1148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 221 226 <span type="species:ncbi:9606">human</span>
###xml 399 403 <span type="species:ncbi:9925">goat</span>
###xml 409 414 <span type="species:ncbi:10090">mouse</span>
###xml 447 452 <span type="species:ncbi:10090">mouse</span>
###xml 968 973 <span type="species:ncbi:9606">Human</span>
###xml 977 982 <span type="species:ncbi:10090">mouse</span>
###xml 1189 1193 <span type="species:ncbi:10090">mice</span>
For human T cell analysis, CD4+ T cells were cultured with PHA (5 microg/ml, Sigma) and hIL-2 (30 Unit/ml, Roche) for two days. Cells were washed twice with PBS and cultured in hIL-2 alone for 1 day before infection. For human cord blood T cells, CD4+ T cells were activated by cross-linking with plate-bound anti-CD3/CD28 antibody (5 microg/ml each, eBioscience). The plates were first coated with goat anti-mouse IgG (10 microg/ml, Caltag). For mouse T cell analysis, CD4+ T cells were cultured on anti-CD3/28 (clone 145-2C11 for anti-CD3, clone 37N for anti-CD28, Memorial Sloan-Kettering Cancer Institute, 5 microg/ml each, 500 microl per well in 24-well-plates coated at 37degreesC for 2-3 h) for 36 h before infection. Virus was added to cells together with polybrene (8 microg/ml). Spin-infection was done by centrifugation at 2,000 rpm for 1 h at R.T. Cells with virus were incubated at 37degreesC for 2 additional hours and then washed twice to remove virus. Human or mouse IL-2 (30 Unit/ml, eBioscience) was added and maintained all the time after infection. 100 unit/ml of mIL-2 was used during the activation and culture of CD4+ T cells purified from Pkctheta-/- and Carma1-/- mice.
###end p 90
###begin title 91
Flow Cytometry
###end title 91
###begin p 92
Flow cytometric analysis was performed on an LSR II cytometer (BD Biosciences) and analyzed using FlowJo software (Tree Star Inc.). Antibodies used in this study were obtained through eBioscience or BD Biosciences.
###end p 92
###begin title 93
Entry assay
###end title 93
###begin p 94
###xml 137 138 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 428 432 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Morner1">[57]</xref>
###xml 459 460 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 655 656 620 621 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 822 823 779 780 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1021 1022 972 973 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1293 1297 1237 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Baba1">[58]</xref>
###xml 125 128 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 154 158 <span type="species:ncbi:11676">VSVG</span>
###xml 931 936 <span type="species:ncbi:10090">mouse</span>
###xml 963 968 <span type="species:ncbi:9606">human</span>
Viruses containing Vpr-beta-lactamase were generated by co-transfection of 10 microg pM310 with 15 microg JRCSF or 15 microg HIV-GFP (Env-) plus 3 microg VSVG into 293T cells in 10 cm plates using the calcium phosphate method. Virus containing supernatants were concentrated by ultracentrifugation at 25,000 rpm for 1.5 h at 4degreesC and resuspended in 200 microl of RPMI medium. Virus titer was determined on GHOST cell lines [57]. For entry assay, 0.5-1x105 cells per well in 96-well-plate were spin-infected with different MOIs of virus for 1 h and incubated for another 2 h at 37degreesC to ensure complete virus entry. Cells were washed once with CO2-independent medium. Cells in each well were provided with 30 microl loading reagent (6x, Protocol for Beta-lactamase loading solutions, Invitrogen) and 150 microl CO2-independent medium supplemented with 10% serum and IL-2. Cells were incubated at 18-20degreesC for 2 h for mouse T cells and overnight for human T cells. After incubation, cells were washed with CO2-independent medium and fixed with PFA. Entry efficiency was analyzed by flow cytometry using FITC and DAPI channels, for un-cleaved substrate and cleaved product respectively. Virus without Vpr-beta-lactamase was used for gating control. R5 inhibitor TAK-779 (1 microM) [58] was used to confirm R5-dependent entry.
###end p 94
###begin title 95
RT assay
###end title 95
###begin p 96
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 585 587 571 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 615 619 601 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Triques1">[59]</xref>
###xml 621 625 607 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Julias1">[60]</xref>
###xml 1346 1367 1290 1311 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCTCTGGTTAGACCAGATCTG</named-content>
###xml 1377 1398 1321 1342 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GTCTGAGGGATCTCTAGTTAC</named-content>
###xml 1459 1461 1403 1405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 1487 1514 1431 1458 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTTTAGTCAGTGTGGAAAATCTGTAGC</named-content>
###xml 1524 1542 1468 1486 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TACTCACCAGTCGCCGCC</named-content>
###xml 1550 1582 1494 1526 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">FAM-TCGACGCAGGACTCGGCTTGCT-TAMRA</named-content>
###xml 1612 1634 1556 1578 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TAGACCAGATCTGAGCCTGGGA</named-content>
###xml 1645 1668 1589 1612 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GTAGTTCTGC CAATCAGGGAAG</named-content>
###xml 1676 1713 1620 1657 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">FAM-AGCCTCAATAAAGCTTGCCTTGAGTGC-TAMRA</named-content>
###xml 1935 1960 1879 1904 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTCACAACTCTCGGT GGATGGTGG</named-content>
###xml 1968 1988 1912 1932 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GACCTTTGGAAGAGCAGTCG</named-content>
###xml 2017 2035 1961 1979 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TACTCACCAGTCGCCGCC</named-content>
###xml 2045 2067 1989 2011 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GAGCGTGGGTAGAGAGAGGAAG</named-content>
###xml 6 11 <span type="species:ncbi:10090">mouse</span>
###xml 85 88 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 94 98 <span type="species:ncbi:11676">VSVG</span>
###xml 647 650 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 911 916 <span type="species:ncbi:9606">human</span>
###xml 921 926 <span type="species:ncbi:10090">mouse</span>
###xml 1837 1840 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1876 1881 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1993 1998 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2369 2374 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
5x105 mouse CD4+ T cells were activated with anti-CD3/28 in 48-well-plates for 36 h. HIV-GFP (VSVG pseudotyped, MOI = 2, benzonase treated) was used for spin-infection. Cells were collected at 0, 1, 2, 3, 6, 9, 12, 15 and 24 h post-infection, washed with PBS and frozen at -80degreesC. As a control, AZT (15 microM) was added at different time points and samples were collected starting from the next time-point. Total DNA was extracted by DNeasy kit (Qiagen) or phenol and dissolved in 50 microl AE buffer (Qiagen). Real-time PCRs were done using primers and probes specific for U5, 2nd transfer and 2-LTR circles [59], [60], Serial dilutions of HIV-GFP or 2-LTR plasmid in genomic DNA were used to generate a standard curve in each plate. Calculation of cell number was determined based on real-time PCR for gene encoding eukaryotic18S rRNA (Hs99999901_s1, Taqman, Applied Biosystem) with common sequence for human and mouse. Real-time PCRs were performed using QuantiTect Multiplex PCR mix (Qiagen) in the i-Cycler Sequence Detection System (Bio-Rad). The running conditions and primer sequences were as the follows. For 2-LTR circles, 95degreesC 5 min, then 95degreesC 45 s, 55degreesC 1 min, 72degreesC 1 min for 40 cycles. All others, 95degreesC 5 min, then 95degreesC 45 s, 60degreesC 1 min for 40 cycles. Primer sequences for U5: Forward TCTCTGGTTAGACCAGATCTG, Reverse GTCTGAGGGATCTCTAGTTAC, probe FAM-AGCCTCAATAAAGCT TGCCTTGAGTGC-TAMRA. Primers for 2nd strand transfer: Forward TTTTAGTCAGTGTGGAAAATCTGTAGC, reverse TACTCACCAGTCGCCGCC probe: FAM-TCGACGCAGGACTCGGCTTGCT-TAMRA. Primers for 2-LTR: Forward, TAGACCAGATCTGAGCCTGGGA, reverse, GTAGTTCTGC CAATCAGGGAAG, probe FAM-AGCCTCAATAAAGCTTGCCTTGAGTGC-TAMRA. To quantify copy numbers of integrated provirus, extracted DNAs were subjected to a first-round PCR to amplify integrated HIV signals using primers specific for HIV-1 and retrotransposon B2. Primer sequences were: B2-1: TTCACAACTCTCGGT GGATGGTGG; B2-2: GACCTTTGGAAGAGCAGTCG and HIV-1 primers: NL750RC: TACTCACCAGTCGCCGCC; NL800R: GAGCGTGGGTAGAGAGAGGAAG. Samples were denatured at 95degreesC for 3 min, followed by 30 cycles at 95degreesC for 45 s, 55degreesC for 1 min, and 72degreesC for 3 min. Products generated from this first round of amplification were diluted in water (1:1,200) and subjected to real-time PCR using primers and probe specific for HIV-1 U5.
###end p 96
###begin title 97
Viral RNA analysis
###end title 97
###begin p 98
###xml 136 137 136 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 72 75 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 81 85 <span type="species:ncbi:11676">VSVG</span>
Total RNA was purified using Qiagen RNeasy kit from cells infected with HIV-GFP (VSVG) for 2 d. cDNAs were generated from RNA by RNase H-reverse transcriptase (Invitrogen) using random primers. Real-time PCR was done using primers specific for U5 and 18S rRNA. As control, no reverse transcriptase was added at the time of cDNA preparation.
###end p 98
###begin title 99
Gag protein analysis
###end title 99
###begin p 100
###xml 25 28 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 34 38 <span type="species:ncbi:11676">VSVG</span>
###xml 607 612 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 832 837 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 982 987 <span type="species:ncbi:9606">human</span>
###xml 992 997 <span type="species:ncbi:10090">mouse</span>
Cells were infected with HIV-GFP (VSVG) in the presence or absence of AZT (10 microM). One day post infection, cells were treated with 0.01-0.04% pronase to remove the virus stuck to the plasma membrane. Two days following infection, cell pellets and supernatants were separated after centrifugation (2,000x g, 5 min) and frozen at -80degreesC. Cells were lysed in RIPA buffer (10 mM Tris, 150 mM NaCl, 0.1% SDS, 1% Triton, 1% Deoxycholate, 5 mM EDTA). p24 in cell lysates and supernatants was measured by ELISA. ELISA was set up using primary and secondary p24 antibody purchased from CLINIQA. Recombinant HIV-1 p24 was included for standard curves. For western blots, aliquots of cell lysates were separated on 12% acrylamide gradient gels and transferred to PVDF membrane. Western blots were probed with a monoclonal antibody to HIV-1 p24 (NIH AIDs Research and Reference Reagent Program). Membranes were stripped and re-probed with anti-tubulin (Sigma, antibody recognizes both human and mouse tubulin) as loading control.
###end p 100
###begin title 101
Infectivity assays
###end title 101
###begin p 102
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002035-Derdeyn1">[38]</xref>
###xml 11 16 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 218 223 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Infectious HIV-1 in supernatants was quantified by using the Tzmbl cell line [38]. Briefly, Tzmbl cells (HeLa cells expressing hCD4, CXCR4 and CCR5, NIH AIDS reagents) were seeded in 48-well plates and inoculated with HIV-1-containing supernatant, which was serially diluted to make sure the infection was not saturated. AZT and TAK-779 were added at 16 h post-infection to prevent secondary infection. Thirty-six hours later, the cells were lysed and firefly luciferase activity was determined (Promega).
###end p 102
###begin title 103
Electron Microscopy
###end title 103
###begin p 104
###xml 188 189 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 188 189 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>+</sup></italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 9 14 <span type="species:ncbi:10090">mouse</span>
###xml 42 45 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 51 55 <span type="species:ncbi:11676">VSVG</span>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 143 148 <span type="species:ncbi:10090">mouse</span>
Human or mouse T cells were infected with HIV-GFP (VSVG) at MOI of 2. For human cells, 3 d after infection, cells were pelleted and fixed. For mouse T cells, cells were FACS sorted for GFP+ cells and allowed to recover overnight at 37degreesC. Cells were resuspended in 1 ml of PBS, transferred to 1.5 ml Eppendorf tubes and centrifuged at 800xg for 1 minute. Pellets were fixed in 2.5% glutaraldehyde for 2 h at 4degreesC and post-fixed with 1% osmium tetroxide for 1.5 h at room temperature, then processed in a standard manner and embedded in Embed 812 (Electron Microscopy Sciences, Hatfield, PA). Semi-thin sections were cut at 1 microm and stained with 1% Toluidine Blue to evaluate the quality of preservation. Ultrathin sections (60 nm) were cut, mounted on formover coated copper grids and stained with uranyl acetate and lead citrate by standard methods. Stained grids were examined using a Philips CM-12 election microscope and photographed with a Gatan (1kx1k) digital camera.
###end p 104
###begin title 105
Supporting Information
###end title 105
###begin p 106
###xml 188 196 185 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002035-g001">Figure 1</xref>
###xml 0 4 <span type="species:ncbi:11676">VSVG</span>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 76 80 <span type="species:ncbi:11676">VSVG</span>
###xml 93 98 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
VSVG mediates efficient entry into mouse and human T cells. Entry assay for VSVG-pseudotyped HIV-1 containing Vpr-beta-lactamase at MOI of 0.04 was performed as described in the legend to Figure 1.
###end p 106
###begin p 107
(0.90 MB EPS)
###end p 107
###begin p 108
Click here for additional data file.
###end p 108
###begin p 109
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Benzonase treatment did not affect the infectivity of HIV-1. Dilutions of the viruses before and after benzonase treatment were added to Tzmbl reporter cells. Firefly luciferase assays were done at 48 h post-infection.
###end p 109
###begin p 110
(0.64 MB EPS)
###end p 110
###begin p 111
Click here for additional data file.
###end p 111
###begin p 112
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
###xml 112 127 <span type="species:ncbi:10090">transgenic mice</span>
###xml 178 181 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 187 191 <span type="species:ncbi:11676">VSVG</span>
PI3K mediated pathways are important for HIV-1 infection in primary mouse T cells. CD4+ T cells from hCyclin T1 transgenic mice were activated with anti-CD3/28 and infected with HIV-GFP (VSVG). PI3K inhibitors wortmannin and Ly294002 were added at the time of infection at concentrations indicated and removed at 24 h post infection. DMSO was used as the control. Infection efficiency was assayed by FACS for GFP expression at 48 h post infection.
###end p 112
###begin p 113
(0.66 MB EPS)
###end p 113
###begin p 114
Click here for additional data file.
###end p 114
###begin p 115
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
###xml 415 420 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We thank Nathaniel Landau, Stephen Goff, Benjamin Chen, Derya Unutmaz, Mark Muesing, and members of the Littman Lab for advice and discussion. We thank Hairong Huo for the help on PKCtheta and CARMA1 knockout mice, Rajat Varma for the WASp knockout mice, Michael D. Miller (Merck), Michael Topper (Aaron Diamond) and Mark Sharkey (UMass) for plasmids, and Nathaniel Landau and Benjamin Chen for the 3T3 cell lines. HIV-1 inhibitors were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAD, NIH. We thank Alice Liang for EM analysis and Peter Lopez for cell sorting.
###end p 115
###begin title 116
References
###end title 116
###begin article-title 117
###xml 27 30 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice.
###end article-title 117
###begin article-title 118
###xml 17 22 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Animal models of HIV-1 disease.
###end article-title 118
###begin article-title 119
###xml 27 55 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells.
###end article-title 119
###begin article-title 120
###xml 33 36 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Dendritic-cell interactions with HIV: infection and viral dissemination.
###end article-title 120
###begin article-title 121
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 44 47 <span type="species:ncbi:10116">rat</span>
###xml 79 114 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1.
###end article-title 121
###begin article-title 122
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 27 31 <span type="species:ncbi:10116">rats</span>
HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription.
###end article-title 122
###begin article-title 123
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 76 81 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 82 97 <span type="species:ncbi:10090">transgenic mice</span>
Human chorionic gonadotropin hormone prevents wasting syndrome and death in HIV-1 transgenic mice.
###end article-title 123
###begin article-title 124
###xml 60 65 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 88 103 <span type="species:ncbi:10090">transgenic mice</span>
Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice.
###end article-title 124
###begin article-title 125
###xml 25 28 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 84 99 <span type="species:ncbi:10090">transgenic mice</span>
Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice.
###end article-title 125
###begin article-title 126
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 48 63 <span type="species:ncbi:10090">transgenic mice</span>
Aberrant regulation of cytokines in HIV-1 TAT72-transgenic mice.
###end article-title 126
###begin article-title 127
###xml 62 67 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA.
###end article-title 127
###begin article-title 128
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 73 108 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 110 115 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 229 234 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate.
###end article-title 128
###begin article-title 129
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 58 61 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection.
###end article-title 129
###begin article-title 130
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 71 86 <span type="species:ncbi:10090">transgenic mice</span>
###xml 117 122 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Disturbed CD4+ T cell homeostasis and in vitro HIV-1 susceptibility in transgenic mice expressing T cell line-tropic HIV-1 receptors.
###end article-title 130
###begin article-title 131
###xml 19 54 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells.
###end article-title 131
###begin article-title 132
###xml 11 46 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 59 65 <span type="species:ncbi:10090">murine</span>
A block to human immunodeficiency virus type 1 assembly in murine cells.
###end article-title 132
###begin article-title 133
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 72 107 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Human chromosome 2 carries a gene required for production of infectious human immunodeficiency virus type 1.
###end article-title 133
###begin article-title 134
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 6 11 <span type="species:ncbi:9606">human</span>
###xml 44 79 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Mouse-human heterokaryons support efficient human immunodeficiency virus type 1 assembly.
###end article-title 134
###begin article-title 135
###xml 32 38 <span type="species:ncbi:10090">murine</span>
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Inhibition of viral assembly in murine cells by HIV-1 matrix.
###end article-title 135
###begin article-title 136
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 59 62 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 78 84 <span type="species:ncbi:10090">murine</span>
Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells.
###end article-title 136
###begin article-title 137
Retroviral mRNA nuclear export elements regulate protein function and virion assembly.
###end article-title 137
###begin article-title 138
###xml 61 96 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 126 132 <span type="species:ncbi:10090">murine</span>
Matrix-induced inhibition of membrane binding contributes to human immunodeficiency virus type 1 particle assembly defects in murine cells.
###end article-title 138
###begin article-title 139
###xml 9 44 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 56 77 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 98 104 <span type="species:ncbi:10090">murine</span>
Chimeric human immunodeficiency virus type 1 containing murine leukemia virus matrix assembles in murine cells.
###end article-title 139
###begin article-title 140
###xml 25 30 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 57 63 <span type="species:ncbi:10090">murine</span>
Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells.
###end article-title 140
###begin article-title 141
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 33 61 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Murine T cells potently restrict human immunodeficiency virus infection.
###end article-title 141
###begin article-title 142
###xml 18 53 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA.
###end article-title 142
###begin article-title 143
###xml 43 48 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cyclophilin, TRIM5, and innate immunity to HIV-1.
###end article-title 143
###begin article-title 144
###xml 43 48 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors.
###end article-title 144
###begin article-title 145
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes.
###end article-title 145
###begin article-title 146
Evaluation of plasmid DNA removal from lentiviral vectors by benzonase treatment.
###end article-title 146
###begin article-title 147
###xml 25 28 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A quantitative assay for HIV DNA integration in vivo.
###end article-title 147
###begin article-title 148
###xml 49 77 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression.
###end article-title 148
###begin article-title 149
###xml 0 28 <span type="species:ncbi:12721">Human immunodeficiency virus</span>
Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles.
###end article-title 149
###begin article-title 150
###xml 41 60 <span type="species:ncbi:11876">avian sarcoma virus</span>
The cellular protein daxx interacts with avian sarcoma virus integrase and viral DNA to repress viral transcription.
###end article-title 150
###begin article-title 151
###xml 56 61 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration.
###end article-title 151
###begin article-title 152
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 25 30 <span type="species:ncbi:9606">human</span>
HIV infection of primary human T cells is determined by tunable thresholds of T cell activation.
###end article-title 152
###begin article-title 153
T-cell-receptor-dependent actin regulatory mechanisms.
###end article-title 153
###begin article-title 154
###xml 15 50 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.
###end article-title 154
###begin article-title 155
###xml 69 74 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 94 99 <span type="species:ncbi:9606">human</span>
Transcription factor GATA-1 potently represses the expression of the HIV-1 coreceptor CCR5 in human T cells and dendritic cells.
###end article-title 155
###begin article-title 156
###xml 27 32 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells.
###end article-title 156
###begin article-title 157
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.
###end article-title 157
###begin article-title 158
###xml 12 47 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells.
###end article-title 158
###begin article-title 159
###xml 74 109 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 113 118 <span type="species:ncbi:10090">mouse</span>
Nuclear import of the preintegration complex is blocked upon infection by human immunodeficiency virus type 1 in mouse cells.
###end article-title 159
###begin article-title 160
###xml 36 71 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
A sensitive, quantitative assay for human immunodeficiency virus type 1 integration.
###end article-title 160
###begin article-title 161
###xml 52 87 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 103 108 <span type="species:ncbi:9606">human</span>
Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.
###end article-title 161
###begin article-title 162
###xml 23 58 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Cyclosporine increases human immunodeficiency virus type 1 vector transduction of primary mouse cells.
###end article-title 162
###begin article-title 163
###xml 40 75 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Phosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophages.
###end article-title 163
###begin article-title 164
Use of kinase inhibitors to dissect signaling pathways.
###end article-title 164
###begin article-title 165
###xml 70 105 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
DNA damage sensors ATM, ATR, DNA-PKcs, and PARP-1 are dispensable for human immunodeficiency virus type 1 integration.
###end article-title 165
###begin article-title 166
Wortmannin potentiates integrase-mediated killing of lymphocytes and reduces the efficiency of stable transduction by retroviruses.
###end article-title 166
###begin article-title 167
Evidence that the retroviral DNA integration process triggers an ATR-dependent DNA damage response.
###end article-title 167
###begin article-title 168
###xml 51 86 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
High viral burden and rapid CD4+ cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo.
###end article-title 168
###begin article-title 169
###xml 42 77 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure.
###end article-title 169
###begin article-title 170
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4.
###end article-title 170
###begin article-title 171
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.
###end article-title 171
###begin article-title 172
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells.
###end article-title 172
###begin article-title 173
###xml 8 43 <span type="species:ncbi:11709">human immunodeficiency virus type 2</span>
###xml 45 50 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 67 72 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.
###end article-title 173
###begin article-title 174
###xml 83 88 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity.
###end article-title 174
###begin article-title 175
###xml 36 71 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes.
###end article-title 175
###begin article-title 176
###xml 36 71 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.
###end article-title 176
###begin p 177
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 177
###begin p 178
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the National Institutes of Health to DRL (AI033856; AI033303). GED is supported by the American Cancer Society-Biogen Idec/Genetech/Ronald Levy Postdoctoral Fellowship. The sponsors had no role in design or conduct of the study.
###end p 178

